US20040181253A1 - Devices and methods for treating vascular malformations - Google Patents

Devices and methods for treating vascular malformations Download PDF

Info

Publication number
US20040181253A1
US20040181253A1 US10/729,432 US72943203A US2004181253A1 US 20040181253 A1 US20040181253 A1 US 20040181253A1 US 72943203 A US72943203 A US 72943203A US 2004181253 A1 US2004181253 A1 US 2004181253A1
Authority
US
United States
Prior art keywords
aneurysm
cover
filaments
carried out
expandable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/729,432
Inventor
Ivan Sepetka
Martin Dieck
Son Gia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stryker Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/729,432 priority Critical patent/US20040181253A1/en
Publication of US20040181253A1 publication Critical patent/US20040181253A1/en
Priority to US12/961,471 priority patent/US20110082491A1/en
Assigned to STRYKER CORPORATION reassignment STRYKER CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CONCENTRIC MEDICAL, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12177Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/12186Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02Dilators made of swellable material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12068Details concerning the detachment of the occluding device from the introduction device detachable by heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12081Details concerning the detachment of the occluding device from the introduction device detachable by inflation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12095Threaded connection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00404Blood vessels other than those in or around the heart
    • A61B2018/00416Treatment of aneurisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1495Electrodes being detachable from a support structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1084Balloon catheters with special features or adapted for special applications having features for increasing the shape stability, the reproducibility or for limiting expansion, e.g. containments, wrapped around fibres, yarns or strands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/36General characteristics of the apparatus related to heating or cooling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082Catheter tip comprising a tool
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies

Definitions

  • the present invention relates to treatment of abnormalities in a patient's vascular system.
  • a specific use of the present invention described below is for the treatment of cerebral aneurysms although the various aspects of the invention described below may also be useful in treating other abnormalities such as arteriovenous malformations (AVM), hypervascular tumors, cavernous carotid fistulas, fibroid tumors, and non-reversible sterilization via fallopial occlusion.
  • AVM arteriovenous malformations
  • hypervascular tumors CAD
  • cavernous carotid fistulas cavernous carotid fistulas
  • fibroid tumors fibroid tumors
  • non-reversible sterilization via fallopial occlusion non-reversible sterilization via fallopial occlusion.
  • Cerebral aneurysms are enlargements of the cerebral vasculature which protrude like a balloon from the wall of a cerebral artery.
  • the cerebral aneurysm has a neck which leads to the parental vessel and a body or “dome” which can vary in diameter from 1-30 mm.
  • the wall of the aneurysm is often weak and can rupture, leading to hemorrhage. Rupture of the aneurysm can kill the patient or leave the patient with permanent or transitory mental and physical deficits.
  • Aneurysms are often treated to prevent rupture, leading to hemorrhage, or to prevent rebleeding of acutely ruptured aneurysms.
  • a conventional method of treating aneurysms is to fill the aneurysm with coils. The coils are introduced into the aneurysm one at a time through a delivery catheter until the aneurysm is filled. The aneurysm eventually becomes a solid mass of coils and thrombus.
  • a problem with the conventional method of using coils to fill aneurysms is that the aneurysm becomes a relatively solid mass due to coils and thrombus contained therein. The mass of coil and thrombus exerts pressure on adjacent areas of the brain which may lead to other problems.
  • Another problem with the conventional method is that the coils must be delivered one at a time into the aneurysm which increases the procedure time and risk to the patient. For large aneurysms, up to twenty coils may be required to fill the aneurysm.
  • a method of treating an aneurysm is provided.
  • An expandable structure is delivered through the vasculature in a collapsed position. Once the expandable structure is at the desired location, such as within a cerebral aneurysm, the expandable structure is expanded.
  • the structure and advantages of the expandable structure are described below.
  • the aneurysm wall is also reduced in size so that the aneurysm does not need to be completely filled in the conventional manner.
  • the expandable shape is sized to be smaller than the aneurysm to permit reducing the size of the aneurysm by at least 30% percent.
  • a preferred method of reducing the size of the aneurysm is to heat the aneurysmal wall, preferably to a temperature of at least 60° and preferably 60-80° C., which causes the aneurysmal wall to shrink.
  • the aneurysm may be heated in any suitable manner and preferred methods are monopolar and bipolar RF, laser, microwave, and simple electrical resistance heating.
  • electrical energy is delivered to the expandable device itself to generate heat.
  • a fluid may be introduced into the aneurysm to prevent clotting during heating and to provide thermal and/or electrical conductance.
  • the fluid may be saline and more preferably hypertonic saline.
  • the aneurysm may also be reduced in size by chemical action.
  • the expandable structure forms a matrix of filaments in the expanded condition.
  • the matrix preferably forms a woven or braided structure, however the filaments may also be randomly oriented, parallel, or non-intersection filaments.
  • the matrix may be flexible filaments, such as platinum ribbon, extending randomly, radially or helically within an expandable, permeable, mesh-like enclosure.
  • the material may also be an expandable material such as polymer, nitinol, stainless steel, tungsten or tantalum and alloys/composites thereof.
  • the expandable device preferably fills a volume of at least 10% of the aneurysm volume, more preferably at least 40% and most preferably at least 60% of aneurysm volume.
  • the expandable device preferably has internal filaments within the volume to quickly form a stable thrombus.
  • An advantage of the expandable device is that a three-dimensional structure forms without requiring separate delivery of a cage and coils as described in International Application WO 99/07293.
  • the expandable device has a deforming portion which plastically deforms when moving to the expanded position. The deformable portion holds the flexible filaments in the expanded position.
  • the aneurysm may be reduced in size until the aneurysmal wall contacts the expandable structure so that the expandable structure supports and reinforces the aneurysmal wall.
  • the expandable structure itself is used to transmit energy to heat the aneurysmal wall which causes the aneurysmal wall to fuse to the expandable structure, thereby reinforcing the aneurysmal wall and preventing migration of the expandable structure into the parental vessel.
  • the aneurysmal wall may be reduced in size together with the expandable device.
  • the expandable structure is a soft mesh which easily collapses when the aneurysmal wall is shrunk.
  • a sealant may be delivered into the aneurysm to ensure that the aneurysm is isolated from the parental artery.
  • An advantage of the present invention is that the sealant is held within a matrix formed by the expandable device which holds the sealant in the aneurysm.
  • the proximal portion of the expandable structure may be insulated to protect the neck of the aneurysm.
  • the insulation may coat only the flexible filaments so that the structure is still permeable to fluid.
  • the insulation may be impermeable to protect the neck from hot fluid slowly expelled into the aneurysm or to isolate the aneurysm entirely from the parental vessel.
  • the expandable device may have one or more expandable sections.
  • the expandable device has two expandable sections wherein energy is delivered to the dome with one of the sections while the second section is insulated to protect the neck.
  • the expandable device may have a locking mechanism for locking the expandable device in the expanded position.
  • the expandable device is naturally biased toward the collapsed position so that the operator may partially deploy the expandable device to determine whether the device has the appropriate size. If the device does not have the appropriate size, the device is collapsed and removed and another device having the appropriate size is introduced. The locking mechanism is then actuated when the user is satisfied with the size of the device.
  • a catheter has a cover which is positioned over the neck of the aneurysm to isolate the aneurysm from the parental vessel.
  • the aneurysm is then reduced in size as explained above while the cover isolates the aneurysm.
  • the cover also protects the patient from hemorrhage by isolating the aneurysm from the parental vessel.
  • the cover may be periodically moved to expel heated fluid into the parental vessel when heating and shrinking the aneurysm.
  • a coil is used to cover the neck of the aneurysm to regulate the flow of hot fluid out of the aneurysm and into the parental vessel.
  • the pitch of the coil can be varied by the operator during deployment to allow faster or slower leakage of hot fluid out of the aneurysm and into the parent artery during heating.
  • a catheter is also provided which has a low-impedance coil, such as flat copper ribbon or other suitable material, disposed in the catheter tip.
  • a low-impedance coil such as flat copper ribbon or other suitable material.
  • Still another device for treating an aneurysm which has a cover which covers the neck of the aneurysm to isolate the aneurysm from a parental vessel.
  • the device also has a lateral extension which is coupled to the cover and extends into the aneurysm when the cover is positioned over the neck of the aneurysm.
  • the cover is preferably a mesh and the lateral extension preferably forms 1-8 loops.
  • the cover is preferably a substantially flat element which is positioned against a wall of the parental vessel around the neck of the aneurysm.
  • the cover preferably extends no more than about 180 degrees around a longitudinal axis of the device when expanded so that branch vessels are not occluded by the cover.
  • the extension is preferably expandable with one end connected to the cover and the other end sliding relative to the cover to permit the extension to expand and contract.
  • the present invention describes still another device for treating an aneurysm which has the cover for covering the neck of an aneurysm.
  • the cover is mounted to an expandable element and is covered by a retractable sheath.
  • the sheath is preferably folded over itself at the distal end so that the cover is exposed as the sheath is pulled back over itself.
  • the cover is preferably wrapped around the expandable member without overlapping folds, flaps or sections.
  • the cover is preferably adhered to the parental vessel wall in any suitable manner such as with an adhesive.
  • the cover may be a sheet of material or a metallic frame having impermeable layer attached thereto.
  • Yet another device for treating an aneurysm which has a plurality of filaments extending between proximal and distal hubs.
  • the filaments preferably form a generally concave surface which covers a neck of an aneurysm when positioned in the aneurysm.
  • the device may also have a concave side opposite the convex side.
  • the filaments form overlapping loops when viewed along an axis through the hubs.
  • the filaments are preferably in a relatively straight configuration when advanced through the delivery catheter to the aneurysm.
  • Still another device for treating an aneurysm has a plurality of filaments, preferably 2-4 filaments, with the proximal ends of the filaments being coupled together and the distal end of the filaments being free.
  • Each of the filaments preferably form a coil in the expanded position.
  • the coils may have a central axis generally lying in the same plane.
  • FIG. 1 is a system for treating a patient's vascular system.
  • FIG. 2 shows an expandable device in a collapsed position.
  • FIG. 3 is a perspective view of the expandable device with the mesh removed.
  • FIG. 4 is a cross-sectional view of the expandable device.
  • FIG. 5 shows the expandable device in an aneurysm.
  • FIG. 6 shows the expandable device detached from the delivery catheter.
  • FIG. 7 shows the expandable device of FIG. 6 with a sealant introduced into a portion of the expandable device.
  • FIG. 8 shows the sealant filling the aneurysm and the expandable device.
  • FIG. 9 shows the expandable device having a proximal portion which is relatively impermeable to the sealant so that the sealant is retained in the aneurysm.
  • FIG. 10 shows the expandable device filled with an expandable material such as random fibers or a coil.
  • FIG. 11 shows another expandable device which is deployed with a balloon in a collapsed position.
  • FIG. 12 shows the expandable device of FIG. 11 in an expanded position.
  • FIG. 13 shows the expandable device reduced in size and the expandable device having a proximal portion which is insulated to protect the neck of the aneurysm.
  • FIG. 14 shows the expandable device of FIG. 11 with simple resistance heating used to shrink a portion of the aneurysm into contact with the expandable device.
  • FIG. 15 shows the use of simple resistance heating to shrink another portion of the aneurysm into contact with the expandable device.
  • FIG. 16 shows a heating device
  • FIG. 17 shows a heating device with the tip curved.
  • FIG. 18 shows the heating device used with the expandable device of FIGS. 11-14.
  • FIG. 19 shows the aneurysm shrunk into contact with the expandable device.
  • FIG. 20 shows the expandable device reduced in size during shrinking of the aneurysm.
  • FIG. 21 shows another expandable device having a locking mechanism for holding the device in the expanded position.
  • FIG. 22 shows the expandable device of FIG. 21 with the device in the expanded position.
  • FIG. 23 shows the device of FIGS. 21 and 22 released from the delivery catheter.
  • FIG. 24 shows a catheter having a cover for isolating an aneurysm from the parental vessel.
  • FIG. 25 is a cross-section of the catheter of FIG. 21 along line A-A.
  • FIG. 26 shows the catheter of FIG. 21 with the cover having a curved shape.
  • FIG. 27 shows the catheter of FIG. 21 isolating an aneurysm.
  • FIG. 28 shows the aneurysm reduced in size and a thrombogenic material and sealant introduced into the aneurysm.
  • FIG. 29 shows only the thrombogenic material in the aneurysm.
  • FIG. 30 shows another expandable device in a collapsed position.
  • FIG. 31 shows the expandable device of FIG. 30 in an expanded position.
  • FIG. 32 is an alternative embodiment of the device of FIGS. 30 and 31.
  • FIG. 33 is another alternative embodiment of the device of FIGS. 30 and 31.
  • FIG. 34 shows a mesh structure for use with any of the expandable devices described herein.
  • FIG. 35 shows a number of expandable device delivered to the aneurysm.
  • FIG. 36 shows the aneurysm of FIG. 35 reduced in size.
  • FIG. 37 shows a coil for regulating flow between an aneurysm and a parent vessel.
  • FIG. 38 shows the coil of FIG. 37 with the windings spaced close together to further impede fluid flow between the aneurysm and the parent vessel.
  • FIG. 39 shows another catheter for heating tissue.
  • FIG. 40 is a cross-sectional view of the distal end of the catheter of FIG. 39.
  • FIG. 41 shows the tip of the catheter of FIGS. 39 and 40 with holes at the distal end of the tip.
  • FIG. 42 shows the tip of the catheter of FIGS. 39 and 40 with holes along the side of the tip.
  • FIG. 43 shows another device for treating an aneurysm.
  • FIG. 44 shows the device of FIG. 43 contained within a catheter for delivery to the aneurysm.
  • FIG. 45 shows an extension of the device positioned in the aneurysm.
  • FIG. 46 shows the device of FIGS. 43-45 deployed with a cover over the neck of the aneurysm.
  • FIG. 47 shows another device for treating an aneurysm.
  • FIG. 48 shows the device of FIG. 47 partially deployed with an expandable element.
  • FIG. 49 shows the device of FIG. 48 with the sheath full retracted and the expandable element expanded to move the cover over the neck of the aneurysm.
  • FIG. 50 shows the device of FIG. 47-49 fully deployed.
  • FIG. 51 shows an alternative cover for the device of FIGS. 47-49.
  • FIG. 52 shows yet another device for treating aneurysms in a collapsed position.
  • FIG. 53 is a side view of the device of FIG. 52 in an expanded condition.
  • FIG. 54 is a plan view of the device of FIG. 52 in an expanded condition.
  • FIG. 55 shows a catheter delivering the device of FIGS. 52-54 to an aneurysm.
  • FIG. 56 shows the device of FIGS. 52-54 deployed in the aneurysm.
  • FIG. 57 shows still another device for treating an aneurysm.
  • FIG. 58 shows the device of FIG. 57 deployed within an aneurysm.
  • FIG. 59 shows a plan view of the device of FIGS. 57 and 58.
  • FIG. 60 shows an alternative to the device of FIGS. 57-59.
  • FIG. 61 shows another alternative to the device of FIGS. 57-59.
  • FIG. 1 a system 2 for introducing an expandable device 4 into a cerebral aneurysm is shown.
  • a first catheter 6 extends through a penetration in the femoral artery and up to the carotid artery.
  • a second catheter 8 is advanced through the first catheter 6 and into the cerebral vasculature to the site of the aneurysm or other abnormality.
  • a delivery catheter 10 is then advanced through the second catheter 8 .
  • the catheter 10 delivers an expandable device 4 which partially fills the aneurysm as will be described below.
  • the system 2 also has an energy supply 12 for heating the aneurysm to shrink the aneurysm as will be described below.
  • the aneurysm is reduced in size as shown in FIG. 6.
  • the aneurysm may be shrunk partially toward the expandable device 4 , into engagement with the expandable device 4 , or may even be shrunk until the expandable device 4 is also reduced in size.
  • An advantage of shrinking the aneurysm is that the aneurysm does not need to be completely filled with coils in the conventional manner.
  • the conventional method of filling the aneurysm with coils creates a relatively solid mass in the aneurysm which can press against adjacent structures leading to further problems.
  • the expandable device 4 is removably mounted to the end of a shaft 5 in the manner described below so that the expandable device 4 may be released in the aneurysm.
  • the expandable device may be released with a mechanical mechanism, a thermoadhesive bond, or an electrolytically or chemically severable bond.
  • the aneurysm may be shrunk in any suitable manner and a preferred method is to heat the aneurysmal wall. Shrinking of the aneurysm may also be accomplished through chemical action.
  • the aneurysmal wall is preferably heated to a temperature of 60-80° C. and preferably at least 70° C. Depending upon the size of the aneurysm, the aneurysmal wall is preferably heated for at least 10 seconds and generally between 10 seconds and 5 minutes.
  • the energy supply 12 supplies RF energy to heat and shrink the aneurysm.
  • the expandable device 4 is preferably configured as a mono-polar RF electrode 14 and the energy supply 12 is preferably an RF generator.
  • a suitable second electrode (not shown) is placed in contact with the patient's skin in the conventional manner.
  • the aneurysm may, of course, be heated with the energy supply being a hot fluid, laser, microwave, bi-polar RF or a resistance heating device without departing from the scope of the invention.
  • the catheter 8 has a lumen 16 coupled to a source of fluid 18 which is preferably a conductive fluid such as saline and more preferably hypertonic saline.
  • the lumen 16 may also be coupled to a source of sealant 20 which may be used to seal the aneurysm as described below.
  • the sealant may be any suitable sealant such as cyanoacrylates, ethylene vinyl-alcohol, cellulose acetate polymers, fibrin glues and other liquid-type tissue sealants.
  • the sealants may also be bioperodable and/or bio-absorbable.
  • the lumen 16 is also coupled to a vacuum source 22 for suctioning fluids and reducing the size of the aneurysm.
  • a source of contrast 24 is also provided for visualization of the aneurysm, vasculature and device positions.
  • a valve 26 couples the lumen 16 to the various sources 18 , 20 , 22 , 24 .
  • the delivery catheter 10 also has a lumen 28 which may be coupled to the sources 18 , 20 , 22 , 24 and discussion of use of the lumen 16 is equally applicable for the lumen 28 .
  • the expandable device 4 has first and second expanding sections 30 , 32 . Although it is preferred to provide both the first and second expanding sections 30 , 32 , the expandable device 4 may include only one expanding section or three or more expanding sections without departing from the scope of the invention.
  • the first section 30 acts as the electrode 14 to deliver RF energy from the energy source 12 to the aneurysm.
  • the second section 32 is insulated and does not transmit energy to the aneurysm so that the neck of the aneurysm is protected.
  • the second section 32 is preferably coated with PTFE, polyamide, FED, or PFA to prevent RF energy transmission. Protecting the neck of the aneurysm also protects peripheral vessels adjacent the neck of the aneurysm.
  • the second expandable section 32 may be permeable to fluid so that heated fluid in the aneurysm may be slowly expelled into the parental vessel to dissipate heat.
  • the second section 32 may also have a fluid impermeable portion 36 adjacent the neck to further protect the neck of the aneurysm as shown in FIG. 9.
  • the fluid impermeable portion 36 is preferably a flexible sheath 38 having a ring or annular shape. The ring shape may interrupted at a radially inner portion 39 so that heated fluid may still be slowly expelled into the parental vessel. Alternatively, the sheath 38 may completely isolate the aneurysm from the parental vessel.
  • the first and second expandable sections 30 , 32 have a number of flexible filaments 40 which move from the collapsed position of FIG. 2 to the expanded position of FIG. 5.
  • the flexible filaments 40 are preferably woven or braided to form a substantially closed-form mesh structure 42 in the expanded position.
  • the filaments 40 and mesh 42 have the characteristics described below and are graphically depicted in the drawings for clarity. A preferred mesh structure 42 is also described with reference to FIG. 34 below.
  • the filaments 40 are positioned over deformable elements 48 which hold the flexible filaments 40 in the expanded position.
  • the deformable elements 48 have columns 50 extending between collars 52 , 53 at the ends.
  • the deformable elements 48 are formed from tubes which have four cut-out sections 54 to form the columns 50 .
  • the collars 52 are then attached to the ends of the tube.
  • the columns 50 are bent outward slightly so that they will buckle outwardly when compressed.
  • the deformable elements 48 are plastically deformed when moving to the expanded position to hold the filaments 40 in the expanded position.
  • the columns 50 may also be designed with curved or sinusoidal shaped sections to improve flexibility.
  • the proximal and distal collars 52 are threaded to engage a threaded tip 58 of a guidewire 60 for manipulating the expandable device 4 .
  • Intermediate collars 62 provide only throughholes to hold and guide the expandable device 4 on the guidewire 60 .
  • the guidewire 60 is pulled until the device 4 is trapped between the delivery catheter 10 and the threaded tip 58 .
  • the guidewire 60 is then rotated to engage the tip 58 with the distal threaded collar 52 .
  • the guidewire 60 can be pulled to expand the device.
  • the deformable elements 48 may still be within their elastic range so that the expandable device 4 will recover the collapsed position when tension is released on the guidewire 60 .
  • the operator may then check to see if the device 4 has the appropriate size and shape for the aneurysm before fully deploying the device. If the operator determines that the device 4 is too small or too large, the device 4 is collapsed and removed and another expandable device of appropriate size advanced to the aneurysm.
  • the operator When the operator is ready to deploy the device 4 , the operator pulls the guidewire 60 so that the deformable elements 48 undergo plastic deformation and move to the expanded position. Even if the device 4 is moved to the expanded position, the operator may still retrieve the device by engaging the proximal collar 53 with the threaded tip 58 and withdrawing the device into the second catheter 8 .
  • the aneurysm is then preferably reduced in size.
  • RF energy is delivered to the first expandable section 30 through the guidewire 60 and a conductive fluid, preferably hypertonic saline, is injected into the aneurysm through the lumen 16 or lumen 28 .
  • FIG. 6 shows the aneurysm reduced in size until the aneurysm engages the first section 30 .
  • the threaded tip 58 is then disengaged from the device 4 leaving the device 4 in the shrunken aneurysm.
  • the sealant 64 from the source of sealant 20 may also be introduced into the entire aneurysm (FIG. 8) or into just the second section 32 (FIG. 7) to seal the aneurysm.
  • An advantage of the present invention over conventional methods is that the sealant 64 is contained within the closed-form mesh structure 42 to prevent escape of the sealant 64 into the parental vessel.
  • a proximal portion 66 may be impermeable to further isolate the aneurysm from the parental vessel.
  • a small amount of the sealant 64 may also be delivered to completely isolate the aneurysm if necessary as shown at dotted-line 68 .
  • the method of the present invention described above may, of course, be practiced with any suitable structure other than the structure of FIGS. 1-9 without departing from the scope of the invention.
  • FIGS. 11-15 another delivery catheter 70 is shown for use with the system of FIG. 1.
  • the delivery catheter 70 is delivered through the first and second catheters described above.
  • the catheter delivers an expandable device 4 A to the aneurysm through the second catheter 8 (see FIG. 1).
  • the delivery catheter 70 has an expandable member 72 , preferably a balloon 74 , for deploying the expandable device 4 A.
  • the device 4 A is configured to retain the expanded position of FIG. 12 after the balloon 74 has been deflated.
  • the delivery catheter 70 has an inflation lumen 72 coupled to a source of inflation fluid 74 for inflating the balloon (FIG. 1).
  • the expandable device 4 A is preferably made of a number of flexible filaments 76 .
  • the filaments 76 are preferably woven or braided but may also be a number of non-woven filaments.
  • the filaments 76 may be any suitable material and a preferred material is platinum alloy (92% platinum, 8% tungsten) wire having a thickness of 0.005-0.003 inch.
  • the expandable device 4 A may take any shape and may have a number of predetermined shapes which can be selected depending upon the shape of the aneurysm and the nature of the patient's vasculature. Referring to FIG. 12, the expandable device 4 A has a simple spherical shape. Although the expandable device 4 A is shown as spherical, the expandable device 4 A preferably has a width to height ratio of more than 1.1, more preferably at least 1.2 and most preferably at least 1.8. The width and height are defined relative to the aneurysm (FIG. 12) and/or relative to a longitudinal axis 76 of the expandable device 4 A.
  • the preferred dimensions provide a relatively large width so that the expandable device 4 A cannot escape through the neck of the aneurysm after expansion.
  • the height of the expandable device 4 A provides clearance for shrinking the aneurysmal toward the expandable device.
  • the width to height ratios are preferred dimensions for all of the embodiments described herein.
  • the aneurysm is preferably reduced in size in any manner described herein.
  • a method of reducing the size of the aneurysm is to deliver energy to the expandable device 4 A from the energy source 12 .
  • the energy may be delivered to the aneurysm by delivering RF energy to the expandable device 4 A with one or more wires 80 passing through the second catheter 8 .
  • the second catheter 8 may be used to deliver fluid, such as hypertonic saline, to the aneurysm.
  • simple resistance heating may also be used by moving the wires 80 into contact with the expandable device 4 A to conduct electricity therebetween as shown in FIG. 14.
  • An advantage of the system is that different portions of the aneurysm can be heated to shrink the aneurysm as shown in FIGS. 14 and 15.
  • the expandable device 4 A may be insulated at a proximal portion 82 so that energy is delivered to the aneurysm dome rather than toward the neck and parental artery.
  • the flexible filaments 76 may be coated with any suitable insulation, such as paraline, and may be applied by spraying, dipping or etching.
  • the expandable device 4 A may also have the flexible sheath 78 over the insulated region to further shield the neck of the aneurysm.
  • a heating device 84 which may be used to heat and shrink the aneurysm.
  • the heating device 84 is advanced into the aneurysm to heat fluid in the aneurysm thereby heating and shrinking the aneurysmal wall.
  • Two insulated wires 86 , 88 are wrapped around a core wire 90 and covered with a sheath 92 along the proximal portion.
  • the sheath 92 forms a lumen 94 therethough which may be coupled to the various sources 18 , 20 , 22 , 24 described above with connector 96 .
  • the distal end of the wires 86 , 88 form proximal and distal electrodes 98 , 100 for bipolar RF heating.
  • the core wire 90 is attached to the distal electrode 100 .
  • An actuator 102 is manipulated to change the distance between the electrodes 98 , 100 and to bend the tip in the manner shown in FIG. 17.
  • the actuator 102 is coupled to the core wire 90 .
  • the device may be configured so that the electrodes 98 , 100 move toward another when the actuator 102 is manipulated, or the device may be configured so that the tip curves as shown in FIG. 17.
  • the tip may be curved to navigate tortuous vessels and may be curved during heating.
  • the distal end of the device 84 is introduced into the aneurysm and the actuator 102 is manipulated to curve the distal end.
  • RF energy is then delivered and a fluid, such as hypertonic saline, is delivered through the second catheter 8 or through the lumen 94 .
  • the aneurysm may be shrunk into contact with the expandable device so that the expandable device 4 A reinforces the aneurysmal wall to prevent rupture.
  • the aneurysmal wall may also be shrunk further so that the expandable device 4 A itself shrinks as shown in FIG. 20.
  • the sealant 64 may also be delivered to further seal the aneurysm.
  • FIGS. 1 and 21- 24 another delivery catheter 110 for treating an aneurysm with the system 2 of FIG. 1 is shown.
  • the catheter 110 is advanced to the carotid artery and the second catheter 8 is advanced through the first catheter 6 to the aneurysm.
  • the delivery catheter 110 extends through the second catheter 8 to deliver an expandable device 4 B to the aneurysm.
  • the delivery catheter 110 has a lumen 112 which may be coupled to one or more of the various sources 18 , 20 , 22 , 24 .
  • the expandable device 4 B is coupled to the energy source 12 for heating and shrinking the aneurysm as will be described below.
  • the expandable device 4 B is movable from the collapsed position of FIG. 21 to the expanded position of FIG. 22.
  • Flexible filaments 114 preferably form a woven or braided mesh structure 116 extending between first and second hubs 118 , 120 .
  • a central post 122 extends from the second hub 120 and has a locking mechanism 124 which engages the first hub 118 to hold the expandable device 4 B in the locked position.
  • An actuator 126 which is preferably a tapered rod 128 , has a threaded connection 130 with the central post 122 . The actuator 126 is pulled to move the locking mechanism 124 into engagement with the second hub 120 .
  • the locking mechanism 124 has spring elements 126 which are naturally biased to the position of FIG. 23.
  • the spring elements 126 are angled proximally so that they are displaced inwardly by the hub 118 when the post 122 and spring elements 126 pass through the hub 118 . After the spring elements 126 have passed through the hub 118 they assume their unbiased shape thereby locking the device 4 B in the expanded position.
  • the locking mechanism 124 may be any suitable locking mechanism.
  • the flexible filaments 114 preferably bias the device 4 B toward the collapsed position so that the operator may partially expand the device to determine whether the device has the appropriate size. If the device is not the appropriate size, the device can be collapsed and withdrawn through the second catheter 8 . After the expandable device 4 B has been expanded, the aneurysmal wall may then be shrunk in any manner described herein.
  • the expandable device is a monopolar RF electrode with the energy source being an RF generator coupled to the actuator 126 .
  • the expandable device 4 B may be insulated along a proximal portion 116 to protect the neck, parental vessel and adjacent vessels as mentioned above.
  • the sealant 64 (FIG. 8) may be introduced to isolate the aneurysm from the parental vessel.
  • the expandable devices 4 , 4 A, and 4 B may be filled with an expandable thrombogenic material 130 .
  • the expandable device 4 is filled with the compressible, thrombogenic material 130 which may be randomly oriented fibers 132 or coils 134 .
  • the material 130 expands to occupy the interior volume of the woven or braided mesh structure 42 .
  • the material 130 may be used with any of the expandable devices described herein without departing from the scope of the invention.
  • the material 130 includes filaments 136
  • the filaments 136 may be helically, radially or randomly oriented within the interior volume of the mesh or braided structure 42 .
  • FIGS. 1 and 24- 27 another catheter 140 for treating an aneurysm with the system of FIG. 1 is shown.
  • the first catheter 6 is introduced through the femoral artery and advanced to the carotid artery.
  • the second catheter 8 is advanced through the first catheter 6 to the aneurysm.
  • the delivery catheter 140 is passed through the second catheter 8 to the aneurysm to treat the aneurysm.
  • the delivery catheter 140 has a lumen 142 which is coupled to the sources of fluid, contrast, sealant and vacuum 18 , 20 , 22 , 24 .
  • the distal end of the catheter 140 has a cover 144 which is positioned over the neck of the aneurysm as shown in FIG. 27.
  • the cover 144 provides temporary isolation of the aneurysm from the parental vessel.
  • the cover 144 is preferably a disc of relatively soft material such as silicone.
  • the cover 144 is preferably configured to cover an area of about 0 . 8 mm 2 to 75 mm 2 and is relatively thin so that the cover 144 does not impede flow through the parental vessel and so that the cover 144 can distort to a small profile when passing through the second catheter 8 .
  • the cover 144 is also preferably impermeable so that the cover 144 can isolate the aneurysm from the parental vessel.
  • the catheter 140 has an electrode 146 which is coupled to the energy source 12 with a wire 148 extending through the catheter 140 .
  • the electrode 146 may be configured as a monopolar RF electrode for delivery of RF energy with a second electrode (not shown) in contact with the patient's skin.
  • a second electrode 150 may be passed through the lumen 142 to provide monopolar or bipolar RF with the first and/or second electrodes 146 , 150 .
  • Shrinking of the aneurysm may, of course, be accomplished with any of the methods described above.
  • the heating device 84 (FIG. 16) may be advanced through the lumen 142 to heat and shrink the aneurysm.
  • the delivery catheter 140 is advanced through the second catheter 8 to the aneurysm.
  • the cover 144 is positioned over the neck of the aneurysm and the aneurysm is heated to shrink the aneurysm.
  • fluid such as hypertonic saline may be infused into the aneurysm through the catheter 140 or second catheter 8 (FIG. 1).
  • the cover 144 may be flexible enough to deflect and permit hot fluid to be slowly expelled into the parental vessel. Alternatively, the cover 144 may be periodically moved away from the neck so that hot fluid in the aneurysm may be slowly expelled into the parental vessel.
  • the aneurysm may be reduced to an acceptable size or partially shrunk and filled with the thrombogenic material 130 and sealant (FIG. 28) or just the material 130 (FIG. 29).
  • the delivery catheter 140 and particularly the cover 144 , have been described in connection with RF delivery, the cover 144 may be incorporated into any of the other catheters described herein or any other catheter without departing from the scope of the invention.
  • FIGS. 30-34 another expandable device 160 is shown for use with the system of FIG. 1.
  • the expandable device 160 is advanced through the second catheter 8 with a delivery catheter 162 .
  • the expandable device has a mesh 166 which covers a spring 160 made of a shape memory material.
  • the expandable device 160 is in the collapsed shape of FIG. 30 when advanced through the second catheter 8 .
  • a wire 161 or other device can be advanced to contact the device 160 to heat the device and the aneurysm.
  • the coil collapses to the shape of FIG. 31 to move the mesh 166 to the expanded condition. Heating of the coil may be undertaken in any manner described herein.
  • An advantage of the device 160 is that the device may be heated together with the aneurysm to deploy the device 160 while shrinking the aneurysm.
  • another device 160 A is shown which is substantially the same as the device 160 except that spring 160 A expands in the middle.
  • FIG. 33 shows still another device 160 B which has a smaller diameter in the middle to impede fluid flow through the spring 160 .
  • the mesh 42 A may be used with any of the expandable devices described herein and the mechanism for expanding and holding the mesh 42 A has been omitted from FIG. 34 for clarity. Any of the actuating and delivery methods and devices described above or any other suitable device may be used with the mesh 42 A.
  • the mesh 42 A preferably has 10-50 filaments, more preferably 20-50 filaments, extending between first and second ends 150 , 152 .
  • the filaments 148 are preferably platinum alloy (such as 92% platinum, 8% tungsten).
  • the filaments 148 preferably form a tube in the collapsed position which has a diameter of no more than 0.020 inch but expands to a diameter of at least 0.200 inch at a central portion 154 .
  • the devices described herein are preferably delivered to the aneurysm to occupy the remaining volume of the aneurysm after shrinking the aneurysm.
  • a number of devices 170 may be delivered to the aneurysm with one of the devices 171 being used to heat and shrink the aneurysm.
  • the devices 170 may be partially or completely insulated in the manner described above to protect the neck while heating and shrinking is accomplished with the device 171 .
  • the devices 170 and 171 are shown spaced apart for clarity but, of course, will be closely packed together when filling the aneurysm.
  • the devices 170 and 171 may be any of the expandable devices described herein or any other suitable device without departing from the scope of the invention.
  • a coil 172 is used to regulate flow of fluid between the aneurysm and the parent vessel.
  • the coil 172 is particularly useful for holding heated fluid in the aneurysm to heat and shrink the aneurysm.
  • the heating device 84 of FIGS. 16 and 17, or any other suitable device for heating the aneurysm is introduced into the aneurysm to heat and shrink the aneurysm.
  • the coil 172 is manipulated by pulling or pushing the coil to retract or deploy the coil 172 from the catheter 8 (see FIG. 1).
  • the pitch of the coil 172 can be varied by pulling or pushing the catheter 8 relative to the coil 172 .
  • the windings of the coil 172 may be close together so that the coil 172 substantially impedes flow between the aneurysm and the parent vessel (FIG. 38) or may be spaced-apart to permit slow leakage of fluid into the parent vessel.
  • the coil 172 may be made of any suitable material and is preferably a shape-memory alloy such as nitinol.
  • the catheter 180 is preferably less than 5 Fr, more preferably 2-4 Fr, and most preferably about 3 Fr in size so that it is small and flexible enough to shrink select portions of the aneurysm as shown by dotted lines 181 in FIG. 39.
  • the catheter 180 may, of course, be sized larger to shrink larger portions of the aneurysm or other tissue structures.
  • the catheter 180 has a tip 182 which is made of a heat-resistant, non-stick material (such as PITFE) so that the tip can contact the tissue during heating without sticking to the tissue.
  • the catheter 180 may also be a hypotube, guidewire or similar device without departing from the scope of the invention.
  • the tip 182 forms a chamber 183 and has holes 186 formed therein for delivery of a conductive fluid as described below.
  • the catheter 180 has a lumen 184 which communicates with the chamber 183 in the tip 182 .
  • the lumen 184 is coupled to the source of fluid 18 (see FIG. 1) which is preferably hypertonic saline.
  • An RF probe 188 passes through the lumen 184 and is coupled to the energy supply 12 (see FIG. 1) which is preferably an RF generator.
  • the RF probe 188 has an electrode 189 positioned in the chamber while a second electrode (not shown) is positioned in contact with the patient's skin in the conventional manner.
  • the holes 183 in the tip 182 may be distributed around the tip 182 (FIG. 39 and 41 ), positioned at the distal end 185 (FIG. 42) or along the sides 187 (FIG. 43) of the tip 182 .
  • the aneurysm may be treated in any other manner described herein.
  • the catheter 180 of FIGS. 39-43 may be used to heat tissue or fluid in connection with any of the other embodiments described herein and in particular as a substitute for the device 84 of FIGS. 16 and 17.
  • the catheter 180 may be used to heat tissue for any other suitable purpose including those described above.
  • the catheter 180 may be useful in treating venous insufficiency, deep vein reflux or for vein stripping.
  • the catheter 180 may be useful for treating urinary incontinence.
  • the expandable device may take any other shape and the sealant may be any other suitable sealant.
  • the dimensions and characteristics of any of the expandable members may be incorporated into any of the other expandable devices described herein without departing from the scope of the invention.
  • the expandable devices are preferably used when shrinking the aneurysm but the expandable devices may have various features which may be useful when simply filling the aneurysm in the conventional manner.
  • FIG. 43-46 another device 200 for treating an aneurysm is shown.
  • the device 200 has a cover 202 that covers the neck of the aneurysm.
  • the device 200 also has a lateral extension 204 extending from the cover 202 into the aneurysm.
  • the lateral extension 204 positions the cover 202 over the neck of the aneurysm and anchors the device 200 to the aneurysm.
  • the cover 202 may be any suitable structure such as a patch or tube so long as the cover 202 is able to block the neck of the aneurysm to isolate the aneurysm from the parental vessel.
  • the cover 202 is preferably substantially flat so that the cover 202 can lie against the wall of the parental vessel around the neck of the aneurysm.
  • the cover 202 is preferably a mesh patch 206 made of a superelastic material such as nitinol.
  • the mesh 206 may have a coating or layer 208 , such as expanded PTFE, which provides the properties and advantages of conventional graft materials.
  • the cover 202 preferably extends no more than one half, and more preferably no more than one third, the circumference of the vessel.
  • the cover 202 preferably extends no more than 180 degrees and more preferably no more than 120 degrees around a longitudinal axis of the device when expanded.
  • the cover 202 may cover more or less of the parental vessel without departing from various aspects of the invention.
  • the lateral extension 204 preferably forms 1-8 loops 210 , and more preferably only one loop, extending from the cover 202 .
  • the loop 210 is preferably formed by an elongate element 212 such as a ribbon made of a superelastic or shape-memory material such as nitinol.
  • An end 211 of the loop 210 is attached to a guide 214 which is attached to the cover 202 .
  • the term loop 210 is intended to include any filament, ribbon, wire or the like having two sides coupled to the cover 202 .
  • the two sides do not have to touch or be adjacent one another to form a loop 210 and, in fact, the loop could be made from a continuous coil wrapped into the cover 202 so long as the coil generally forms 1-8 individual loops 210 extending into the aneurysm.
  • the lateral extension 204 extends laterally from a catheter 216 during deployment so that the catheter 216 can remain aligned with the vessel in the manner shown in FIG. 45.
  • the elongate element 212 extends and slides through the guide 214 .
  • the element 212 has a stop 220 at one end that engages the guide 214 to hold the extension 204 in the expanded condition.
  • the element 212 is preferably biased toward the expanded position of FIGS. 43 and 46 so that the stop 220 naturally engages the guide 214 when the element 212 is released.
  • the element 212 is coupled to a first manipulator 222 with a releasable connection such as a threaded connection 223 or an electrolytically severable bond.
  • the first manipulator 222 is used to move and deploy the device 200 , and in particular the loop 210 , in the manner described below.
  • the device 200 is preferably available in a number of different sizes with the size of the loop 210 and the size of the cover 202 being variable.
  • the size of the loop 210 and cover 202 are selected based upon the geometry of the aneurysm and parental vessel.
  • the device 200 is preferably delivered with the catheter 216 .
  • the device 200 is mounted within the catheter 216 and is advanced out of the catheter 216 and exposed as shown in FIGS. 44-46 when deploying the device 200 .
  • the delivery catheter 200 has a first lumen 224 in which is positioned the first manipulator 222 .
  • a second manipulator 226 holds the cover 202 opposite the first manipulator 222 for moving and deploying the device 200 .
  • a suture 228 or any other releasable connection holds the cover 202 to the second manipulator 226 .
  • the catheter 216 is preferably advanced over a guidewire 230 which is positioned in a guidewire lumen 232 .
  • the catheter 216 preferably has a three-lumen configuration although fewer lumens may be used without departing from the scope of the invention.
  • the device 200 may also be operated by delivering energy, such as RF energy, to the device 200 as now described in connection with methods and systems of the invention.
  • energy such as RF energy
  • the cover 202 preferably does not conduct energy to protect the parental vessel and neck of the aneurysm.
  • the geometry of the aneurysm and parental vessel are determined so that the appropriate size of the device 200 is used.
  • the size of the extension 204 may be selected to be somewhat smaller than the aneurysm particularly when heat is used to shrink the aneurysm with RF energy or the like.
  • the device 200 may also form a number of different shapes that are selected based on the geometry of the aneurysm.
  • the device 200 is introduced into the patient with the catheter 216 in the manner described above and the methods and systems described above are specifically incorporated here.
  • the distal end of the cover 202 and the lateral extension 204 are advanced out of the catheter 216 by manipulating the first and second manipulators 222 , 226 .
  • the first and second manipulators 222 , 226 may be used to expand and retract the device 200 a number of times when attempting to introduce the extension into the aneurysm.
  • the extension 204 expands to occupy space within the aneurysm.
  • Energy may then be delivered to the lateral extension 204 to shrink the aneurysm and/or simply adhere the extension to the aneurysmal wall thereby holding the cover in the proper position.
  • the source of RF energy is coupled to the first manipulator 222 for this purpose. Although the invention may be practiced with delivery of RF energy, various aspects may be practiced without delivering energy to the aneurysm.
  • the device 200 is then released to permit the cover 202 to expand as shown in FIG. 46.
  • the lateral extension 204 helps to orient the cover 202 into the proper position as the cover 202 expands.
  • FIGS. 47-50 still another device 250 for treating an aneurysm is shown.
  • the device 250 has a cover 252 wrapped around an expandable element 254 such as an inflatable balloon 256 .
  • the balloon 256 is inflated through an inflation lumen 257 .
  • a sheath 258 extends over the cover 252 to trap the cover 252 between the sheath 258 and expandable element 254 .
  • the sheath 258 is retracted to expose the cover 252 when deploying the cover 252 as explained below.
  • the sheath 258 is preferably folded over itself at the distal end and is folded back and everted to expose the cover 252 .
  • the sheath 258 is preferably made of a flexible material at the distal end such as a suitable polymer such as polyethylene.
  • the guidewire may engage the expandable element 254 at a connection 259 so that the guidewire helps to stabilize the device 250 during deployment.
  • the cover 252 is preferably wrapped or collapsed by simply wrapping the cover 252 around the expandable element 254 .
  • the cover 252 may overlap itself or may extend around only part of the expandable element 254 .
  • the cover 252 is wrapped around the expandable element 254 without any overlapping flaps, folds or sections.
  • the cover 252 is preferably adhered to the wall of the parental vessel around the neck of the aneurysm.
  • the cover 252 may be adhered to the wall with any suitable method including glue or heat.
  • the cover 252 may also be adhered to the wall using a conventional stent or with a support structure similar to a stent.
  • the cover 252 is adhered to the parental vessel with a biocompatible adhesive 260 such as cyanoacrylate applied to an outer surface of the cover 252 .
  • the sheath 258 covers the adhesive 260 during introduction and advancement of the device 250 .
  • the adhesive 260 may also be activated within the patient using light, heat, RF, radiation, chemical or other suitable activators.
  • FIG. 51 another cover 262 is shown for use with the device 250 wherein the same or similar reference numbers refer to the same or similar structure.
  • the cover 262 has a frame 264 , preferably metallic, and an impermeable portion 266 mounted to the frame 264 .
  • the impermeable portion 266 is preferably PTFE or expanded PTFE and is fused or sutured to the frame 264 .
  • the impermeable portion 266 covers the neck of the aneurysm to isolate the aneurysm.
  • the device 300 has a number of filaments 302 that extend from a proximal hub 304 to a distal hub 306 .
  • the filaments 302 are preferably stainless steel, platinum or nitinol and the hubs 304 , 306 are preferably platinum or a radiopaque polymer.
  • the filaments 302 are attached to the hubs 304 , 306 by solder, weld or glue.
  • the device 300 preferably includes 2-16 filaments 302 and more preferably about 8 filaments 302 .
  • the filaments 302 may be integrally formed with one or both of the hubs 304 , 306 or may be a single filament 302 which is wound around or adhered to the hubs 304 , 306 .
  • the device 300 preferably assumes a generally dish-shaped structure having a generally convex side 308 and a concave side 310 although the device 300 may take any other suitable shape.
  • the device 300 is advanced through a catheter 312 with a manipulator 314 .
  • the device 300 may, of course, be mounted within a sheath (not shown) which is then advanced through the catheter 312 as described above.
  • the manipulator 314 may simply push the device 300 or the device may be releasably attached to the device 300 with a mechanical connection or an electrolytically severable bond.
  • the distal hub 306 is naturally biased toward the proximal hub 304 with the filaments 302 forming loops 314 when expanded (see FIG. 54).
  • the device 300 may be coupled to a source of energy, such as a source of RF energy, which is delivered to heat the device 300 to adhere the device 300 to the aneurysm and/or shrink the aneurysm.
  • a source of energy such as a source of RF energy
  • the device may also be used with other methods of closing an aneurysm such as with a sealant or with conventional coils and the like. The device 300 prevents such embolic material from migrating out of the aneurysm.
  • FIGS. 57-61 yet another device 316 for treating an aneurysm is shown.
  • the device 316 has a manipulator 318 which may simply push the device 316 through a lumen 320 in a catheter 322 or may be releasably attached in any suitable manner.
  • the device 316 has a plurality of filaments 324 each having a proximal end 326 and a distal end 328 .
  • the proximal ends 326 are coupled together at a hub 330 .
  • the filaments 324 are collapsed into a relatively straightened configuration when positioned in the catheter 322 .
  • the filaments 324 expand to occupy space in the aneurysm.
  • the filaments 324 may expand into any suitable shape and preferably expand to form a number of coils 328 .
  • the coils 328 may be oriented in any manner and are preferably oriented with a central axis 330 of at least three coils 328 lying in a common plane 330 .
  • the device 316 may have 2-6 coils 328 and FIG. 59 shows three coils and FIGS. 60 and 61 show two different four coil 328 configurations.
  • the device 316 is deployed in substantially the same manner as the device described above.
  • the catheter 322 is advanced to the aneurysm and the manipulator 318 moves the device 316 out of the catheter and into the aneurysm as shown in FIG. 58.

Abstract

The invention is also directed to a device for treating an aneurysm which has a cover covering the neck of the aneurysm and a lateral portion extending into the aneurysm. The invention is also directed to a cover which is used to cover the neck of the aneurysm thereby isolating the aneurysm from the parental vessel.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • The present application is a continuation in part of U.S. patent application Ser. No. 09/324,359 filed Jun. 2, 1999 which is hereby incorporated by reference for all purposes.[0001]
  • BACKGROUND OF THE INVENTION
  • The present invention relates to treatment of abnormalities in a patient's vascular system. A specific use of the present invention described below is for the treatment of cerebral aneurysms although the various aspects of the invention described below may also be useful in treating other abnormalities such as arteriovenous malformations (AVM), hypervascular tumors, cavernous carotid fistulas, fibroid tumors, and non-reversible sterilization via fallopial occlusion. [0002]
  • Cerebral aneurysms are enlargements of the cerebral vasculature which protrude like a balloon from the wall of a cerebral artery. The cerebral aneurysm has a neck which leads to the parental vessel and a body or “dome” which can vary in diameter from 1-30 mm. [0003]
  • The wall of the aneurysm is often weak and can rupture, leading to hemorrhage. Rupture of the aneurysm can kill the patient or leave the patient with permanent or transitory mental and physical deficits. [0004]
  • Aneurysms are often treated to prevent rupture, leading to hemorrhage, or to prevent rebleeding of acutely ruptured aneurysms. A conventional method of treating aneurysms is to fill the aneurysm with coils. The coils are introduced into the aneurysm one at a time through a delivery catheter until the aneurysm is filled. The aneurysm eventually becomes a solid mass of coils and thrombus. [0005]
  • A problem with the conventional method of using coils to fill aneurysms is that the aneurysm becomes a relatively solid mass due to coils and thrombus contained therein. The mass of coil and thrombus exerts pressure on adjacent areas of the brain which may lead to other problems. Another problem with the conventional method is that the coils must be delivered one at a time into the aneurysm which increases the procedure time and risk to the patient. For large aneurysms, up to twenty coils may be required to fill the aneurysm. [0006]
  • It is an object of the invention to provide improved methods and devices for treating aneurysms. These and other objects of the invention will become evident from the description of the preferred embodiments described below. [0007]
  • SUMMARY OF THE INVENTION
  • In a first aspect of the present invention, a method of treating an aneurysm is provided. An expandable structure is delivered through the vasculature in a collapsed position. Once the expandable structure is at the desired location, such as within a cerebral aneurysm, the expandable structure is expanded. The structure and advantages of the expandable structure are described below. The aneurysm wall is also reduced in size so that the aneurysm does not need to be completely filled in the conventional manner. The expandable shape is sized to be smaller than the aneurysm to permit reducing the size of the aneurysm by at least 30% percent. [0008]
  • A preferred method of reducing the size of the aneurysm is to heat the aneurysmal wall, preferably to a temperature of at least 60° and preferably 60-80° C., which causes the aneurysmal wall to shrink. The aneurysm may be heated in any suitable manner and preferred methods are monopolar and bipolar RF, laser, microwave, and simple electrical resistance heating. In a preferred method, electrical energy is delivered to the expandable device itself to generate heat. A fluid may be introduced into the aneurysm to prevent clotting during heating and to provide thermal and/or electrical conductance. When using RF heating, for example, the fluid may be saline and more preferably hypertonic saline. Although it is preferred to heat the aneurysmal wall to reduce the size of the aneurysm, the aneurysm may also be reduced in size by chemical action. [0009]
  • The expandable structure forms a matrix of filaments in the expanded condition. The matrix preferably forms a woven or braided structure, however the filaments may also be randomly oriented, parallel, or non-intersection filaments. The matrix may be flexible filaments, such as platinum ribbon, extending randomly, radially or helically within an expandable, permeable, mesh-like enclosure. The material may also be an expandable material such as polymer, nitinol, stainless steel, tungsten or tantalum and alloys/composites thereof. [0010]
  • The expandable device preferably fills a volume of at least 10% of the aneurysm volume, more preferably at least 40% and most preferably at least 60% of aneurysm volume. The expandable device preferably has internal filaments within the volume to quickly form a stable thrombus. An advantage of the expandable device is that a three-dimensional structure forms without requiring separate delivery of a cage and coils as described in International Application WO 99/07293. In another aspect, the expandable device has a deforming portion which plastically deforms when moving to the expanded position. The deformable portion holds the flexible filaments in the expanded position. [0011]
  • The aneurysm may be reduced in size until the aneurysmal wall contacts the expandable structure so that the expandable structure supports and reinforces the aneurysmal wall. In a particularly advantageous embodiment of the invention, the expandable structure itself is used to transmit energy to heat the aneurysmal wall which causes the aneurysmal wall to fuse to the expandable structure, thereby reinforcing the aneurysmal wall and preventing migration of the expandable structure into the parental vessel. [0012]
  • In another aspect of the invention, the aneurysmal wall may be reduced in size together with the expandable device. In a preferred embodiment, the expandable structure is a soft mesh which easily collapses when the aneurysmal wall is shrunk. [0013]
  • Various optional steps and structure may also be provided. For example, a sealant may be delivered into the aneurysm to ensure that the aneurysm is isolated from the parental artery. An advantage of the present invention is that the sealant is held within a matrix formed by the expandable device which holds the sealant in the aneurysm. [0014]
  • The proximal portion of the expandable structure may be insulated to protect the neck of the aneurysm. The insulation may coat only the flexible filaments so that the structure is still permeable to fluid. Alternatively, the insulation may be impermeable to protect the neck from hot fluid slowly expelled into the aneurysm or to isolate the aneurysm entirely from the parental vessel. [0015]
  • The expandable device may have one or more expandable sections. In an embodiment, the expandable device has two expandable sections wherein energy is delivered to the dome with one of the sections while the second section is insulated to protect the neck. [0016]
  • The expandable device may have a locking mechanism for locking the expandable device in the expanded position. The expandable device is naturally biased toward the collapsed position so that the operator may partially deploy the expandable device to determine whether the device has the appropriate size. If the device does not have the appropriate size, the device is collapsed and removed and another device having the appropriate size is introduced. The locking mechanism is then actuated when the user is satisfied with the size of the device. [0017]
  • In still another aspect of the present invention, a catheter has a cover which is positioned over the neck of the aneurysm to isolate the aneurysm from the parental vessel. The aneurysm is then reduced in size as explained above while the cover isolates the aneurysm. The cover also protects the patient from hemorrhage by isolating the aneurysm from the parental vessel. The cover may be periodically moved to expel heated fluid into the parental vessel when heating and shrinking the aneurysm. [0018]
  • In yet another aspect of the present invention, a coil is used to cover the neck of the aneurysm to regulate the flow of hot fluid out of the aneurysm and into the parental vessel. The pitch of the coil can be varied by the operator during deployment to allow faster or slower leakage of hot fluid out of the aneurysm and into the parent artery during heating. [0019]
  • A catheter is also provided which has a low-impedance coil, such as flat copper ribbon or other suitable material, disposed in the catheter tip. Upon infusion of saline through the catheter and passage of RF energy through the coil, the saline is heated and conducts electrical energy to heat the fluid. [0020]
  • These and other aspects and advantages of the invention will become evident from the following description, drawings and claims. [0021]
  • Still another device for treating an aneurysm is provided which has a cover which covers the neck of the aneurysm to isolate the aneurysm from a parental vessel. The device also has a lateral extension which is coupled to the cover and extends into the aneurysm when the cover is positioned over the neck of the aneurysm. [0022]
  • The cover is preferably a mesh and the lateral extension preferably forms 1-8 loops. The cover is preferably a substantially flat element which is positioned against a wall of the parental vessel around the neck of the aneurysm. The cover preferably extends no more than about 180 degrees around a longitudinal axis of the device when expanded so that branch vessels are not occluded by the cover. The extension is preferably expandable with one end connected to the cover and the other end sliding relative to the cover to permit the extension to expand and contract. [0023]
  • The present invention describes still another device for treating an aneurysm which has the cover for covering the neck of an aneurysm. The cover is mounted to an expandable element and is covered by a retractable sheath. The sheath is preferably folded over itself at the distal end so that the cover is exposed as the sheath is pulled back over itself. The cover is preferably wrapped around the expandable member without overlapping folds, flaps or sections. The cover is preferably adhered to the parental vessel wall in any suitable manner such as with an adhesive. The cover may be a sheet of material or a metallic frame having impermeable layer attached thereto. [0024]
  • Yet another device for treating an aneurysm is provided which has a plurality of filaments extending between proximal and distal hubs. The filaments preferably form a generally concave surface which covers a neck of an aneurysm when positioned in the aneurysm. The device may also have a concave side opposite the convex side. The filaments form overlapping loops when viewed along an axis through the hubs. The filaments are preferably in a relatively straight configuration when advanced through the delivery catheter to the aneurysm. [0025]
  • Still another device for treating an aneurysm has a plurality of filaments, preferably 2-4 filaments, with the proximal ends of the filaments being coupled together and the distal end of the filaments being free. Each of the filaments preferably form a coil in the expanded position. The coils may have a central axis generally lying in the same plane.[0026]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a system for treating a patient's vascular system. [0027]
  • FIG. 2 shows an expandable device in a collapsed position. [0028]
  • FIG. 3 is a perspective view of the expandable device with the mesh removed. [0029]
  • FIG. 4 is a cross-sectional view of the expandable device. [0030]
  • FIG. 5 shows the expandable device in an aneurysm. [0031]
  • FIG. 6 shows the expandable device detached from the delivery catheter. [0032]
  • FIG. 7 shows the expandable device of FIG. 6 with a sealant introduced into a portion of the expandable device. [0033]
  • FIG. 8 shows the sealant filling the aneurysm and the expandable device. [0034]
  • FIG. 9 shows the expandable device having a proximal portion which is relatively impermeable to the sealant so that the sealant is retained in the aneurysm. [0035]
  • FIG. 10 shows the expandable device filled with an expandable material such as random fibers or a coil. [0036]
  • FIG. 11 shows another expandable device which is deployed with a balloon in a collapsed position. [0037]
  • FIG. 12 shows the expandable device of FIG. 11 in an expanded position. [0038]
  • FIG. 13 shows the expandable device reduced in size and the expandable device having a proximal portion which is insulated to protect the neck of the aneurysm. [0039]
  • FIG. 14 shows the expandable device of FIG. 11 with simple resistance heating used to shrink a portion of the aneurysm into contact with the expandable device. [0040]
  • FIG. 15 shows the use of simple resistance heating to shrink another portion of the aneurysm into contact with the expandable device. [0041]
  • FIG. 16 shows a heating device. [0042]
  • FIG. 17 shows a heating device with the tip curved. [0043]
  • FIG. 18 shows the heating device used with the expandable device of FIGS. 11-14. [0044]
  • FIG. 19 shows the aneurysm shrunk into contact with the expandable device. [0045]
  • FIG. 20 shows the expandable device reduced in size during shrinking of the aneurysm. [0046]
  • FIG. 21 shows another expandable device having a locking mechanism for holding the device in the expanded position. [0047]
  • FIG. 22 shows the expandable device of FIG. 21 with the device in the expanded position. [0048]
  • FIG. 23 shows the device of FIGS. 21 and 22 released from the delivery catheter. [0049]
  • FIG. 24 shows a catheter having a cover for isolating an aneurysm from the parental vessel. [0050]
  • FIG. 25 is a cross-section of the catheter of FIG. 21 along line A-A. [0051]
  • FIG. 26 shows the catheter of FIG. 21 with the cover having a curved shape. [0052]
  • FIG. 27 shows the catheter of FIG. 21 isolating an aneurysm. [0053]
  • FIG. 28 shows the aneurysm reduced in size and a thrombogenic material and sealant introduced into the aneurysm. [0054]
  • FIG. 29 shows only the thrombogenic material in the aneurysm. [0055]
  • FIG. 30 shows another expandable device in a collapsed position. [0056]
  • FIG. 31 shows the expandable device of FIG. 30 in an expanded position. [0057]
  • FIG. 32 is an alternative embodiment of the device of FIGS. 30 and 31. [0058]
  • FIG. 33 is another alternative embodiment of the device of FIGS. 30 and 31. [0059]
  • FIG. 34 shows a mesh structure for use with any of the expandable devices described herein. [0060]
  • FIG. 35 shows a number of expandable device delivered to the aneurysm. [0061]
  • FIG. 36 shows the aneurysm of FIG. 35 reduced in size. [0062]
  • FIG. 37 shows a coil for regulating flow between an aneurysm and a parent vessel. [0063]
  • FIG. 38 shows the coil of FIG. 37 with the windings spaced close together to further impede fluid flow between the aneurysm and the parent vessel. [0064]
  • FIG. 39 shows another catheter for heating tissue. [0065]
  • FIG. 40 is a cross-sectional view of the distal end of the catheter of FIG. 39. [0066]
  • FIG. 41 shows the tip of the catheter of FIGS. 39 and 40 with holes at the distal end of the tip. [0067]
  • FIG. 42 shows the tip of the catheter of FIGS. 39 and 40 with holes along the side of the tip. [0068]
  • FIG. 43 shows another device for treating an aneurysm. [0069]
  • FIG. 44 shows the device of FIG. 43 contained within a catheter for delivery to the aneurysm. [0070]
  • FIG. 45 shows an extension of the device positioned in the aneurysm. [0071]
  • FIG. 46 shows the device of FIGS. 43-45 deployed with a cover over the neck of the aneurysm. [0072]
  • FIG. 47 shows another device for treating an aneurysm. [0073]
  • FIG. 48 shows the device of FIG. 47 partially deployed with an expandable element. [0074]
  • FIG. 49 shows the device of FIG. 48 with the sheath full retracted and the expandable element expanded to move the cover over the neck of the aneurysm. [0075]
  • FIG. 50 shows the device of FIG. 47-49 fully deployed. [0076]
  • FIG. 51 shows an alternative cover for the device of FIGS. 47-49. [0077]
  • FIG. 52 shows yet another device for treating aneurysms in a collapsed position. [0078]
  • FIG. 53 is a side view of the device of FIG. 52 in an expanded condition. [0079]
  • FIG. 54 is a plan view of the device of FIG. 52 in an expanded condition. [0080]
  • FIG. 55 shows a catheter delivering the device of FIGS. 52-54 to an aneurysm. [0081]
  • FIG. 56 shows the device of FIGS. 52-54 deployed in the aneurysm. [0082]
  • FIG. 57 shows still another device for treating an aneurysm. [0083]
  • FIG. 58 shows the device of FIG. 57 deployed within an aneurysm. [0084]
  • FIG. 59 shows a plan view of the device of FIGS. 57 and 58. [0085]
  • FIG. 60 shows an alternative to the device of FIGS. 57-59. [0086]
  • FIG. 61 shows another alternative to the device of FIGS. 57-59.[0087]
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Referring to FIG. 1, a [0088] system 2 for introducing an expandable device 4 into a cerebral aneurysm is shown. A first catheter 6 extends through a penetration in the femoral artery and up to the carotid artery. A second catheter 8 is advanced through the first catheter 6 and into the cerebral vasculature to the site of the aneurysm or other abnormality. A delivery catheter 10 is then advanced through the second catheter 8. The catheter 10 delivers an expandable device 4 which partially fills the aneurysm as will be described below. The system 2 also has an energy supply 12 for heating the aneurysm to shrink the aneurysm as will be described below.
  • After the [0089] expandable device 4 has been delivered to the aneurysm and expanded, the aneurysm is reduced in size as shown in FIG. 6. The aneurysm may be shrunk partially toward the expandable device 4, into engagement with the expandable device 4, or may even be shrunk until the expandable device 4 is also reduced in size. An advantage of shrinking the aneurysm is that the aneurysm does not need to be completely filled with coils in the conventional manner. The conventional method of filling the aneurysm with coils creates a relatively solid mass in the aneurysm which can press against adjacent structures leading to further problems. The expandable device 4 is removably mounted to the end of a shaft 5 in the manner described below so that the expandable device 4 may be released in the aneurysm. The expandable device may be released with a mechanical mechanism, a thermoadhesive bond, or an electrolytically or chemically severable bond.
  • The aneurysm may be shrunk in any suitable manner and a preferred method is to heat the aneurysmal wall. Shrinking of the aneurysm may also be accomplished through chemical action. The aneurysmal wall is preferably heated to a temperature of 60-80° C. and preferably at least 70° C. Depending upon the size of the aneurysm, the aneurysmal wall is preferably heated for at least 10 seconds and generally between 10 seconds and 5 minutes. [0090]
  • In the preferred system of FIG. 1, the [0091] energy supply 12 supplies RF energy to heat and shrink the aneurysm. The expandable device 4 is preferably configured as a mono-polar RF electrode 14 and the energy supply 12 is preferably an RF generator. A suitable second electrode (not shown) is placed in contact with the patient's skin in the conventional manner. The aneurysm may, of course, be heated with the energy supply being a hot fluid, laser, microwave, bi-polar RF or a resistance heating device without departing from the scope of the invention.
  • Referring to FIGS. 1 and 4, the [0092] catheter 8 has a lumen 16 coupled to a source of fluid 18 which is preferably a conductive fluid such as saline and more preferably hypertonic saline. The lumen 16 may also be coupled to a source of sealant 20 which may be used to seal the aneurysm as described below. The sealant may be any suitable sealant such as cyanoacrylates, ethylene vinyl-alcohol, cellulose acetate polymers, fibrin glues and other liquid-type tissue sealants. The sealants may also be bioperodable and/or bio-absorbable. The lumen 16 is also coupled to a vacuum source 22 for suctioning fluids and reducing the size of the aneurysm. A source of contrast 24 is also provided for visualization of the aneurysm, vasculature and device positions. A valve 26 couples the lumen 16 to the various sources 18, 20, 22, 24. The delivery catheter 10 also has a lumen 28 which may be coupled to the sources 18, 20, 22, 24 and discussion of use of the lumen 16 is equally applicable for the lumen 28.
  • Referring to FIGS. 2, 3 and [0093] 5, the expandable device 4 has first and second expanding sections 30, 32. Although it is preferred to provide both the first and second expanding sections 30, 32, the expandable device 4 may include only one expanding section or three or more expanding sections without departing from the scope of the invention. The first section 30 acts as the electrode 14 to deliver RF energy from the energy source 12 to the aneurysm. The second section 32 is insulated and does not transmit energy to the aneurysm so that the neck of the aneurysm is protected. The second section 32 is preferably coated with PTFE, polyamide, FED, or PFA to prevent RF energy transmission. Protecting the neck of the aneurysm also protects peripheral vessels adjacent the neck of the aneurysm.
  • The second [0094] expandable section 32 may be permeable to fluid so that heated fluid in the aneurysm may be slowly expelled into the parental vessel to dissipate heat. The second section 32 may also have a fluid impermeable portion 36 adjacent the neck to further protect the neck of the aneurysm as shown in FIG. 9. The fluid impermeable portion 36 is preferably a flexible sheath 38 having a ring or annular shape. The ring shape may interrupted at a radially inner portion 39 so that heated fluid may still be slowly expelled into the parental vessel. Alternatively, the sheath 38 may completely isolate the aneurysm from the parental vessel.
  • The first and second [0095] expandable sections 30, 32 have a number of flexible filaments 40 which move from the collapsed position of FIG. 2 to the expanded position of FIG. 5. The flexible filaments 40 are preferably woven or braided to form a substantially closed-form mesh structure 42 in the expanded position. The filaments 40 and mesh 42 have the characteristics described below and are graphically depicted in the drawings for clarity. A preferred mesh structure 42 is also described with reference to FIG. 34 below.
  • Referring again to FIGS. 2 and 3, the [0096] filaments 40 are positioned over deformable elements 48 which hold the flexible filaments 40 in the expanded position. Referring to FIG. 3, the deformable elements 48 have columns 50 extending between collars 52, 53 at the ends. The deformable elements 48 are formed from tubes which have four cut-out sections 54 to form the columns 50. The collars 52 are then attached to the ends of the tube. The columns 50 are bent outward slightly so that they will buckle outwardly when compressed. As will be described in further detail below, the deformable elements 48 are plastically deformed when moving to the expanded position to hold the filaments 40 in the expanded position. The columns 50 may also be designed with curved or sinusoidal shaped sections to improve flexibility.
  • Referring to FIG. 4, the proximal and [0097] distal collars 52 are threaded to engage a threaded tip 58 of a guidewire 60 for manipulating the expandable device 4. Intermediate collars 62 provide only throughholes to hold and guide the expandable device 4 on the guidewire 60. When expanding the device 4, the guidewire 60 is pulled until the device 4 is trapped between the delivery catheter 10 and the threaded tip 58. The guidewire 60 is then rotated to engage the tip 58 with the distal threaded collar 52. When the tip 58 is threaded into engagement with the distal collar 52, the guidewire 60 can be pulled to expand the device. When the device 4 is partially expanded, the deformable elements 48 may still be within their elastic range so that the expandable device 4 will recover the collapsed position when tension is released on the guidewire 60. The operator may then check to see if the device 4 has the appropriate size and shape for the aneurysm before fully deploying the device. If the operator determines that the device 4 is too small or too large, the device 4 is collapsed and removed and another expandable device of appropriate size advanced to the aneurysm.
  • When the operator is ready to deploy the [0098] device 4, the operator pulls the guidewire 60 so that the deformable elements 48 undergo plastic deformation and move to the expanded position. Even if the device 4 is moved to the expanded position, the operator may still retrieve the device by engaging the proximal collar 53 with the threaded tip 58 and withdrawing the device into the second catheter 8.
  • After the [0099] expandable device 4 has been moved to the expanded position, the aneurysm is then preferably reduced in size. In a preferred method, RF energy is delivered to the first expandable section 30 through the guidewire 60 and a conductive fluid, preferably hypertonic saline, is injected into the aneurysm through the lumen 16 or lumen 28. FIG. 6 shows the aneurysm reduced in size until the aneurysm engages the first section 30. The threaded tip 58 is then disengaged from the device 4 leaving the device 4 in the shrunken aneurysm.
  • As an optional step, the [0100] sealant 64 from the source of sealant 20 may also be introduced into the entire aneurysm (FIG. 8) or into just the second section 32 (FIG. 7) to seal the aneurysm. An advantage of the present invention over conventional methods is that the sealant 64 is contained within the closed-form mesh structure 42 to prevent escape of the sealant 64 into the parental vessel. Referring to FIG. 9, a proximal portion 66 may be impermeable to further isolate the aneurysm from the parental vessel. A small amount of the sealant 64 may also be delivered to completely isolate the aneurysm if necessary as shown at dotted-line 68. The method of the present invention described above may, of course, be practiced with any suitable structure other than the structure of FIGS. 1-9 without departing from the scope of the invention.
  • Referring to FIGS. 11-15, another [0101] delivery catheter 70 is shown for use with the system of FIG. 1. The delivery catheter 70 is delivered through the first and second catheters described above. The catheter delivers an expandable device 4A to the aneurysm through the second catheter 8 (see FIG. 1).
  • The [0102] delivery catheter 70 has an expandable member 72, preferably a balloon 74, for deploying the expandable device 4A. The device 4A is configured to retain the expanded position of FIG. 12 after the balloon 74 has been deflated. The delivery catheter 70 has an inflation lumen 72 coupled to a source of inflation fluid 74 for inflating the balloon (FIG. 1).
  • The [0103] expandable device 4A is preferably made of a number of flexible filaments 76. The filaments 76 are preferably woven or braided but may also be a number of non-woven filaments. The filaments 76 may be any suitable material and a preferred material is platinum alloy (92% platinum, 8% tungsten) wire having a thickness of 0.005-0.003 inch.
  • The [0104] expandable device 4A may take any shape and may have a number of predetermined shapes which can be selected depending upon the shape of the aneurysm and the nature of the patient's vasculature. Referring to FIG. 12, the expandable device 4A has a simple spherical shape. Although the expandable device 4A is shown as spherical, the expandable device 4A preferably has a width to height ratio of more than 1.1, more preferably at least 1.2 and most preferably at least 1.8. The width and height are defined relative to the aneurysm (FIG. 12) and/or relative to a longitudinal axis 76 of the expandable device 4A. The preferred dimensions provide a relatively large width so that the expandable device 4A cannot escape through the neck of the aneurysm after expansion. The height of the expandable device 4A provides clearance for shrinking the aneurysmal toward the expandable device. The width to height ratios are preferred dimensions for all of the embodiments described herein.
  • Once the [0105] expandable device 4A has been delivered to the aneurysm, the aneurysm is preferably reduced in size in any manner described herein. A method of reducing the size of the aneurysm is to deliver energy to the expandable device 4A from the energy source 12. The energy may be delivered to the aneurysm by delivering RF energy to the expandable device 4A with one or more wires 80 passing through the second catheter 8. During RF delivery, the second catheter 8 may be used to deliver fluid, such as hypertonic saline, to the aneurysm.
  • Referring to FIGS. 14 and 15, simple resistance heating may also be used by moving the [0106] wires 80 into contact with the expandable device 4A to conduct electricity therebetween as shown in FIG. 14. An advantage of the system is that different portions of the aneurysm can be heated to shrink the aneurysm as shown in FIGS. 14 and 15.
  • The [0107] expandable device 4A may be insulated at a proximal portion 82 so that energy is delivered to the aneurysm dome rather than toward the neck and parental artery. The flexible filaments 76 may be coated with any suitable insulation, such as paraline, and may be applied by spraying, dipping or etching. The expandable device 4A may also have the flexible sheath 78 over the insulated region to further shield the neck of the aneurysm.
  • Referring to FIG. 16, a [0108] heating device 84 is shown which may be used to heat and shrink the aneurysm. The heating device 84 is advanced into the aneurysm to heat fluid in the aneurysm thereby heating and shrinking the aneurysmal wall. Two insulated wires 86, 88 are wrapped around a core wire 90 and covered with a sheath 92 along the proximal portion. The sheath 92 forms a lumen 94 therethough which may be coupled to the various sources 18, 20, 22, 24 described above with connector 96. The distal end of the wires 86, 88 form proximal and distal electrodes 98, 100 for bipolar RF heating. The core wire 90 is attached to the distal electrode 100.
  • An [0109] actuator 102 is manipulated to change the distance between the electrodes 98, 100 and to bend the tip in the manner shown in FIG. 17. The actuator 102 is coupled to the core wire 90. The device may be configured so that the electrodes 98, 100 move toward another when the actuator 102 is manipulated, or the device may be configured so that the tip curves as shown in FIG. 17. The tip may be curved to navigate tortuous vessels and may be curved during heating. In use, the distal end of the device 84 is introduced into the aneurysm and the actuator 102 is manipulated to curve the distal end. RF energy is then delivered and a fluid, such as hypertonic saline, is delivered through the second catheter 8 or through the lumen 94.
  • Referring to FIGS. 18 and 19, the aneurysm may be shrunk into contact with the expandable device so that the [0110] expandable device 4A reinforces the aneurysmal wall to prevent rupture. The aneurysmal wall may also be shrunk further so that the expandable device 4A itself shrinks as shown in FIG. 20. After the aneurysm has been reduced in size, the sealant 64 may also be delivered to further seal the aneurysm.
  • Referring to FIGS. 1 and 21-[0111] 24, another delivery catheter 110 for treating an aneurysm with the system 2 of FIG. 1 is shown. The catheter 110 is advanced to the carotid artery and the second catheter 8 is advanced through the first catheter 6 to the aneurysm. The delivery catheter 110 extends through the second catheter 8 to deliver an expandable device 4B to the aneurysm. The delivery catheter 110 has a lumen 112 which may be coupled to one or more of the various sources 18, 20, 22, 24. The expandable device 4B is coupled to the energy source 12 for heating and shrinking the aneurysm as will be described below.
  • The [0112] expandable device 4B is movable from the collapsed position of FIG. 21 to the expanded position of FIG. 22. Flexible filaments 114 preferably form a woven or braided mesh structure 116 extending between first and second hubs 118, 120. A central post 122 extends from the second hub 120 and has a locking mechanism 124 which engages the first hub 118 to hold the expandable device 4B in the locked position. An actuator 126, which is preferably a tapered rod 128, has a threaded connection 130 with the central post 122. The actuator 126 is pulled to move the locking mechanism 124 into engagement with the second hub 120. The locking mechanism 124 has spring elements 126 which are naturally biased to the position of FIG. 23. The spring elements 126 are angled proximally so that they are displaced inwardly by the hub 118 when the post 122 and spring elements 126 pass through the hub 118. After the spring elements 126 have passed through the hub 118 they assume their unbiased shape thereby locking the device 4B in the expanded position. The locking mechanism 124 may be any suitable locking mechanism.
  • The [0113] flexible filaments 114 preferably bias the device 4B toward the collapsed position so that the operator may partially expand the device to determine whether the device has the appropriate size. If the device is not the appropriate size, the device can be collapsed and withdrawn through the second catheter 8. After the expandable device 4B has been expanded, the aneurysmal wall may then be shrunk in any manner described herein. In the preferred embodiment of FIG. 21, the expandable device is a monopolar RF electrode with the energy source being an RF generator coupled to the actuator 126. The expandable device 4B may be insulated along a proximal portion 116 to protect the neck, parental vessel and adjacent vessels as mentioned above. After the aneurysmal wall has been reduced in size, the sealant 64 (FIG. 8) may be introduced to isolate the aneurysm from the parental vessel.
  • In another aspect of the present invention, the [0114] expandable devices 4, 4A, and 4B may be filled with an expandable thrombogenic material 130. Referring to FIG. 10, the expandable device 4 is filled with the compressible, thrombogenic material 130 which may be randomly oriented fibers 132 or coils 134. When the expandable device 4 is expanded, the material 130 expands to occupy the interior volume of the woven or braided mesh structure 42. The material 130 may be used with any of the expandable devices described herein without departing from the scope of the invention. When the material 130 includes filaments 136, the filaments 136 may be helically, radially or randomly oriented within the interior volume of the mesh or braided structure 42.
  • Referring to FIGS. 1 and 24-[0115] 27, another catheter 140 for treating an aneurysm with the system of FIG. 1 is shown. The first catheter 6 is introduced through the femoral artery and advanced to the carotid artery. The second catheter 8 is advanced through the first catheter 6 to the aneurysm. The delivery catheter 140 is passed through the second catheter 8 to the aneurysm to treat the aneurysm.
  • The [0116] delivery catheter 140 has a lumen 142 which is coupled to the sources of fluid, contrast, sealant and vacuum 18, 20, 22, 24. The distal end of the catheter 140 has a cover 144 which is positioned over the neck of the aneurysm as shown in FIG. 27. The cover 144 provides temporary isolation of the aneurysm from the parental vessel. The cover 144 is preferably a disc of relatively soft material such as silicone. The cover 144 is preferably configured to cover an area of about 0.8 mm2 to 75 mm2 and is relatively thin so that the cover 144 does not impede flow through the parental vessel and so that the cover 144 can distort to a small profile when passing through the second catheter 8. The cover 144 is also preferably impermeable so that the cover 144 can isolate the aneurysm from the parental vessel.
  • The [0117] catheter 140 has an electrode 146 which is coupled to the energy source 12 with a wire 148 extending through the catheter 140. The electrode 146 may be configured as a monopolar RF electrode for delivery of RF energy with a second electrode (not shown) in contact with the patient's skin. Alternatively, a second electrode 150 may be passed through the lumen 142 to provide monopolar or bipolar RF with the first and/or second electrodes 146, 150. Shrinking of the aneurysm may, of course, be accomplished with any of the methods described above. For example, the heating device 84 (FIG. 16) may be advanced through the lumen 142 to heat and shrink the aneurysm.
  • Use of the [0118] delivery catheter 140 is now described, the delivery catheter 140 is advanced through the second catheter 8 to the aneurysm. The cover 144 is positioned over the neck of the aneurysm and the aneurysm is heated to shrink the aneurysm. When using RF heating, fluid such as hypertonic saline may be infused into the aneurysm through the catheter 140 or second catheter 8 (FIG. 1). The cover 144 may be flexible enough to deflect and permit hot fluid to be slowly expelled into the parental vessel. Alternatively, the cover 144 may be periodically moved away from the neck so that hot fluid in the aneurysm may be slowly expelled into the parental vessel. The aneurysm may be reduced to an acceptable size or partially shrunk and filled with the thrombogenic material 130 and sealant (FIG. 28) or just the material 130 (FIG. 29). Although the delivery catheter 140, and particularly the cover 144, have been described in connection with RF delivery, the cover 144 may be incorporated into any of the other catheters described herein or any other catheter without departing from the scope of the invention.
  • Referring to FIGS. 30-34, another [0119] expandable device 160 is shown for use with the system of FIG. 1. The expandable device 160 is advanced through the second catheter 8 with a delivery catheter 162. The expandable device has a mesh 166 which covers a spring 160 made of a shape memory material. The expandable device 160 is in the collapsed shape of FIG. 30 when advanced through the second catheter 8. After the expandable device 160 is within the aneurysm, a wire 161 or other device can be advanced to contact the device 160 to heat the device and the aneurysm. Upon heating, the coil collapses to the shape of FIG. 31 to move the mesh 166 to the expanded condition. Heating of the coil may be undertaken in any manner described herein. An advantage of the device 160 is that the device may be heated together with the aneurysm to deploy the device 160 while shrinking the aneurysm. Referring to FIG. 32, another device 160A is shown which is substantially the same as the device 160 except that spring 160A expands in the middle. FIG. 33 shows still another device 160B which has a smaller diameter in the middle to impede fluid flow through the spring 160.
  • Referring to FIG. 34, another [0120] mesh 42A is shown. The mesh 42A may be used with any of the expandable devices described herein and the mechanism for expanding and holding the mesh 42A has been omitted from FIG. 34 for clarity. Any of the actuating and delivery methods and devices described above or any other suitable device may be used with the mesh 42A. The mesh 42A preferably has 10-50 filaments, more preferably 20-50 filaments, extending between first and second ends 150, 152. The filaments 148 are preferably platinum alloy (such as 92% platinum, 8% tungsten). The filaments 148 preferably form a tube in the collapsed position which has a diameter of no more than 0.020 inch but expands to a diameter of at least 0.200 inch at a central portion 154.
  • The devices described herein are preferably delivered to the aneurysm to occupy the remaining volume of the aneurysm after shrinking the aneurysm. Referring to FIGS. 35 and 36, a number of [0121] devices 170 may be delivered to the aneurysm with one of the devices 171 being used to heat and shrink the aneurysm. The devices 170 may be partially or completely insulated in the manner described above to protect the neck while heating and shrinking is accomplished with the device 171. The devices 170 and 171 are shown spaced apart for clarity but, of course, will be closely packed together when filling the aneurysm. The devices 170 and 171 may be any of the expandable devices described herein or any other suitable device without departing from the scope of the invention.
  • Referring to FIG. 37, another system for reducing the size of an aneurysm is shown. A [0122] coil 172 is used to regulate flow of fluid between the aneurysm and the parent vessel. The coil 172 is particularly useful for holding heated fluid in the aneurysm to heat and shrink the aneurysm. The heating device 84 of FIGS. 16 and 17, or any other suitable device for heating the aneurysm, is introduced into the aneurysm to heat and shrink the aneurysm. The coil 172 is manipulated by pulling or pushing the coil to retract or deploy the coil 172 from the catheter 8 (see FIG. 1). The pitch of the coil 172 can be varied by pulling or pushing the catheter 8 relative to the coil 172. The windings of the coil 172 may be close together so that the coil 172 substantially impedes flow between the aneurysm and the parent vessel (FIG. 38) or may be spaced-apart to permit slow leakage of fluid into the parent vessel. The coil 172 may be made of any suitable material and is preferably a shape-memory alloy such as nitinol.
  • Referring to FIGS. 39 and 40, another [0123] catheter 180 for heating and shrinking an aneurysm is shown. The catheter 180 is preferably less than 5 Fr, more preferably 2-4 Fr, and most preferably about 3 Fr in size so that it is small and flexible enough to shrink select portions of the aneurysm as shown by dotted lines 181 in FIG. 39. The catheter 180 may, of course, be sized larger to shrink larger portions of the aneurysm or other tissue structures. The catheter 180 has a tip 182 which is made of a heat-resistant, non-stick material (such as PITFE) so that the tip can contact the tissue during heating without sticking to the tissue. The catheter 180 may also be a hypotube, guidewire or similar device without departing from the scope of the invention. The tip 182 forms a chamber 183 and has holes 186 formed therein for delivery of a conductive fluid as described below.
  • The [0124] catheter 180 has a lumen 184 which communicates with the chamber 183 in the tip 182. The lumen 184 is coupled to the source of fluid 18 (see FIG. 1) which is preferably hypertonic saline. An RF probe 188 passes through the lumen 184 and is coupled to the energy supply 12 (see FIG. 1) which is preferably an RF generator. The RF probe 188 has an electrode 189 positioned in the chamber while a second electrode (not shown) is positioned in contact with the patient's skin in the conventional manner. When the conductive fluid is delivered through the lumen 184, electrical energy is conducted by the conductive fluid to heat the aneurysm. The holes 183 in the tip 182 may be distributed around the tip 182 (FIG. 39 and 41), positioned at the distal end 185 (FIG. 42) or along the sides 187 (FIG. 43) of the tip 182.
  • After the volume of the aneurysm has been reduced, the aneurysm may be treated in any other manner described herein. Furthermore, the [0125] catheter 180 of FIGS. 39-43 may be used to heat tissue or fluid in connection with any of the other embodiments described herein and in particular as a substitute for the device 84 of FIGS. 16 and 17. Finally, the catheter 180 may be used to heat tissue for any other suitable purpose including those described above. For example, the catheter 180 may be useful in treating venous insufficiency, deep vein reflux or for vein stripping. Furthermore, the catheter 180 may be useful for treating urinary incontinence.
  • While the above is a description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. For example, the expandable device may take any other shape and the sealant may be any other suitable sealant. Furthermore, the dimensions and characteristics of any of the expandable members may be incorporated into any of the other expandable devices described herein without departing from the scope of the invention. Finally, the expandable devices are preferably used when shrinking the aneurysm but the expandable devices may have various features which may be useful when simply filling the aneurysm in the conventional manner. [0126]
  • Referring to FIG. 43-46, another [0127] device 200 for treating an aneurysm is shown. The device 200 has a cover 202 that covers the neck of the aneurysm. The device 200 also has a lateral extension 204 extending from the cover 202 into the aneurysm. The lateral extension 204 positions the cover 202 over the neck of the aneurysm and anchors the device 200 to the aneurysm.
  • The [0128] cover 202 may be any suitable structure such as a patch or tube so long as the cover 202 is able to block the neck of the aneurysm to isolate the aneurysm from the parental vessel. The cover 202 is preferably substantially flat so that the cover 202 can lie against the wall of the parental vessel around the neck of the aneurysm. In the preferred embodiment, the cover 202 is preferably a mesh patch 206 made of a superelastic material such as nitinol. The mesh 206 may have a coating or layer 208, such as expanded PTFE, which provides the properties and advantages of conventional graft materials. The cover 202 preferably extends no more than one half, and more preferably no more than one third, the circumference of the vessel. Stated another way, the cover 202 preferably extends no more than 180 degrees and more preferably no more than 120 degrees around a longitudinal axis of the device when expanded. Of course, the cover 202 may cover more or less of the parental vessel without departing from various aspects of the invention.
  • The [0129] lateral extension 204 preferably forms 1-8 loops 210, and more preferably only one loop, extending from the cover 202. The loop 210 is preferably formed by an elongate element 212 such as a ribbon made of a superelastic or shape-memory material such as nitinol. An end 211 of the loop 210 is attached to a guide 214 which is attached to the cover 202. The term loop 210 is intended to include any filament, ribbon, wire or the like having two sides coupled to the cover 202. The two sides do not have to touch or be adjacent one another to form a loop 210 and, in fact, the loop could be made from a continuous coil wrapped into the cover 202 so long as the coil generally forms 1-8 individual loops 210 extending into the aneurysm. The lateral extension 204 extends laterally from a catheter 216 during deployment so that the catheter 216 can remain aligned with the vessel in the manner shown in FIG. 45.
  • The [0130] elongate element 212 extends and slides through the guide 214. The element 212 has a stop 220 at one end that engages the guide 214 to hold the extension 204 in the expanded condition. The element 212 is preferably biased toward the expanded position of FIGS. 43 and 46 so that the stop 220 naturally engages the guide 214 when the element 212 is released. The element 212 is coupled to a first manipulator 222 with a releasable connection such as a threaded connection 223 or an electrolytically severable bond. The first manipulator 222 is used to move and deploy the device 200, and in particular the loop 210, in the manner described below. As will be explained below, the device 200 is preferably available in a number of different sizes with the size of the loop 210 and the size of the cover 202 being variable. The size of the loop 210 and cover 202 are selected based upon the geometry of the aneurysm and parental vessel.
  • The [0131] device 200 is preferably delivered with the catheter 216. The device 200 is mounted within the catheter 216 and is advanced out of the catheter 216 and exposed as shown in FIGS. 44-46 when deploying the device 200. The delivery catheter 200 has a first lumen 224 in which is positioned the first manipulator 222. A second manipulator 226 holds the cover 202 opposite the first manipulator 222 for moving and deploying the device 200. A suture 228 or any other releasable connection holds the cover 202 to the second manipulator 226. The catheter 216 is preferably advanced over a guidewire 230 which is positioned in a guidewire lumen 232. The catheter 216 preferably has a three-lumen configuration although fewer lumens may be used without departing from the scope of the invention.
  • The [0132] device 200 may also be operated by delivering energy, such as RF energy, to the device 200 as now described in connection with methods and systems of the invention. When delivering energy, such as RF energy, the cover 202 preferably does not conduct energy to protect the parental vessel and neck of the aneurysm.
  • Additional methods of the present invention are now described in connection with the preferred embodiment of FIGS. 43-46 although other suitable devices may be used. Before introducing the [0133] device 200 into the patient, the geometry of the aneurysm and parental vessel are determined so that the appropriate size of the device 200 is used. For example, the size of the extension 204 may be selected to be somewhat smaller than the aneurysm particularly when heat is used to shrink the aneurysm with RF energy or the like. The device 200 may also form a number of different shapes that are selected based on the geometry of the aneurysm.
  • After selecting the appropriate size of the [0134] device 200, the device 200 is introduced into the patient with the catheter 216 in the manner described above and the methods and systems described above are specifically incorporated here. When the device 200 is positioned at the aneurysm, the distal end of the cover 202 and the lateral extension 204 are advanced out of the catheter 216 by manipulating the first and second manipulators 222, 226. The first and second manipulators 222, 226 may be used to expand and retract the device 200 a number of times when attempting to introduce the extension into the aneurysm. Once the extension 204 is properly positioned within the aneurysm, the extension 204 expands to occupy space within the aneurysm.
  • Energy may then be delivered to the [0135] lateral extension 204 to shrink the aneurysm and/or simply adhere the extension to the aneurysmal wall thereby holding the cover in the proper position. The source of RF energy is coupled to the first manipulator 222 for this purpose. Although the invention may be practiced with delivery of RF energy, various aspects may be practiced without delivering energy to the aneurysm. The device 200 is then released to permit the cover 202 to expand as shown in FIG. 46. The lateral extension 204 helps to orient the cover 202 into the proper position as the cover 202 expands.
  • Referring to FIGS. 47-50, still another [0136] device 250 for treating an aneurysm is shown. The device 250 has a cover 252 wrapped around an expandable element 254 such as an inflatable balloon 256. The balloon 256 is inflated through an inflation lumen 257. A sheath 258 extends over the cover 252 to trap the cover 252 between the sheath 258 and expandable element 254. The sheath 258 is retracted to expose the cover 252 when deploying the cover 252 as explained below. The sheath 258 is preferably folded over itself at the distal end and is folded back and everted to expose the cover 252. The sheath 258 is preferably made of a flexible material at the distal end such as a suitable polymer such as polyethylene. The guidewire may engage the expandable element 254 at a connection 259 so that the guidewire helps to stabilize the device 250 during deployment.
  • The [0137] cover 252 is preferably wrapped or collapsed by simply wrapping the cover 252 around the expandable element 254. The cover 252 may overlap itself or may extend around only part of the expandable element 254. In the preferred embodiment, the cover 252 is wrapped around the expandable element 254 without any overlapping flaps, folds or sections.
  • The [0138] cover 252 is preferably adhered to the wall of the parental vessel around the neck of the aneurysm. The cover 252 may be adhered to the wall with any suitable method including glue or heat. The cover 252 may also be adhered to the wall using a conventional stent or with a support structure similar to a stent. In a preferred method, the cover 252 is adhered to the parental vessel with a biocompatible adhesive 260 such as cyanoacrylate applied to an outer surface of the cover 252. The sheath 258 covers the adhesive 260 during introduction and advancement of the device 250. The adhesive 260 may also be activated within the patient using light, heat, RF, radiation, chemical or other suitable activators.
  • Referring to FIG. 51, another [0139] cover 262 is shown for use with the device 250 wherein the same or similar reference numbers refer to the same or similar structure. The cover 262 has a frame 264, preferably metallic, and an impermeable portion 266 mounted to the frame 264. The impermeable portion 266 is preferably PTFE or expanded PTFE and is fused or sutured to the frame 264. The impermeable portion 266 covers the neck of the aneurysm to isolate the aneurysm.
  • Referring to FIG. 52-56, another [0140] device 300 for treating an aneurysm is shown. The device 300 has a number of filaments 302 that extend from a proximal hub 304 to a distal hub 306. The filaments 302 are preferably stainless steel, platinum or nitinol and the hubs 304, 306 are preferably platinum or a radiopaque polymer. The filaments 302 are attached to the hubs 304, 306 by solder, weld or glue. The device 300 preferably includes 2-16 filaments 302 and more preferably about 8 filaments 302. The filaments 302 may be integrally formed with one or both of the hubs 304, 306 or may be a single filament 302 which is wound around or adhered to the hubs 304, 306. The device 300 preferably assumes a generally dish-shaped structure having a generally convex side 308 and a concave side 310 although the device 300 may take any other suitable shape.
  • The [0141] device 300 is advanced through a catheter 312 with a manipulator 314. The device 300 may, of course, be mounted within a sheath (not shown) which is then advanced through the catheter 312 as described above. The manipulator 314 may simply push the device 300 or the device may be releasably attached to the device 300 with a mechanical connection or an electrolytically severable bond. When the device 300 exits the catheter 312, the distal hub 306 is naturally biased toward the proximal hub 304 with the filaments 302 forming loops 314 when expanded (see FIG. 54).
  • The [0142] device 300 may be coupled to a source of energy, such as a source of RF energy, which is delivered to heat the device 300 to adhere the device 300 to the aneurysm and/or shrink the aneurysm. The device may also be used with other methods of closing an aneurysm such as with a sealant or with conventional coils and the like. The device 300 prevents such embolic material from migrating out of the aneurysm.
  • Referring to FIGS. 57-61, yet another [0143] device 316 for treating an aneurysm is shown. The device 316 has a manipulator 318 which may simply push the device 316 through a lumen 320 in a catheter 322 or may be releasably attached in any suitable manner. The device 316 has a plurality of filaments 324 each having a proximal end 326 and a distal end 328. The proximal ends 326 are coupled together at a hub 330.
  • The [0144] filaments 324 are collapsed into a relatively straightened configuration when positioned in the catheter 322. When the filaments 326 are deployed out of the catheter 322, the filaments 324 expand to occupy space in the aneurysm. The filaments 324 may expand into any suitable shape and preferably expand to form a number of coils 328. The coils 328 may be oriented in any manner and are preferably oriented with a central axis 330 of at least three coils 328 lying in a common plane 330. The device 316 may have 2-6 coils 328 and FIG. 59 shows three coils and FIGS. 60 and 61 show two different four coil 328 configurations. The device 316 is deployed in substantially the same manner as the device described above. The catheter 322 is advanced to the aneurysm and the manipulator 318 moves the device 316 out of the catheter and into the aneurysm as shown in FIG. 58.

Claims (58)

What is claimed is:
1. A method of treating an aneurysm, comprising the steps of:
providing a device having a cover and a lateral extension, the cover and extension being movable from a collapsed position to an expanded position;
advancing the device through a patient's vascular system to an aneurysm with the cover in the collapsed position;
moving the lateral extension into the neck of the aneurysm and the cover over the neck of the aneurysm to isolate the aneurysm from the parental vessel.
2. The method of claim 1, wherein:
the providing step is carried out with the cover being a substantially flat element; and
the moving step is carried out with the cover being positioned against a wall of the parental vessel around the neck of the aneurysm.
3. The method of claim 1, wherein:
the moving step is carried out with the lateral extension extending laterally outward from a side of the device.
4. The method of claim 1, wherein:
the providing step is carried out with the lateral extension forming at least one loop extending into the aneurysm.
5. The method of claim 1, wherein:
the providing step is carried out with the lateral extension forming 1-8 loops.
6. The method of claim 1, wherein:
the providing step is carried out with the cover extending around no more than half the circumference of the vessel.
7. The method of claim 1, wherein:
the providing step is carried out with the cover extending around no more than one third the circumference of the vessel.
8. The method of claim 1, further comprising the steps of:
coupling at least the lateral extension to a source of energy; and
delivering the energy to the lateral extension after the introducing step.
9. The method of claim 8, wherein:
the coupling and delivering steps are carried out with the source of energy being RF energy.
10. The method of claim 1, wherein:
the providing step is carried out with the cover being wrapped around the expandable element.
11. The method of claim 10, wherein:
the providing step is carried out with the cover being wrapped around the expandable element without overlapping folds.
12. A device for treating an aneurysm, comprising:
a cover which covers the neck of the aneurysm to isolate the aneurysm from a parental vessel; and
a lateral extension coupled to the cover, the lateral extension extending from the cover and into the aneurysm when the cover is positioned over the neck of the aneurysm.
13. The device of claim 12, further comprising:
the cover comprises a mesh; and
the lateral extension comprises a loop.
14. The method of claim 12, wherein:
the cover is a substantially flat element which is positioned against a wall of the parental vessel around the neck of the aneurysm when the lateral extension is positioned in the aneurysm.
15. The device of claim 12, wherein:
the lateral extension forms 1-8 loops.
16. The device of claim 12, wherein:
the providing step is carried out with the lateral extension forming only one loop.
17. The device of claim 12, wherein:
the loop has a first side attached to the cover.
18. The device of claim 12, wherein:
the loop is slidable relative to the cover when the loop expands.
19. The device of claim 12, wherein:
the cover extends no more than about 180 degrees around a longitudinal axis of the device when expanded so that side branch vessels are not occluded by the cover.
20. The device of claim 12, wherein:
the cover extends no more than about 120 degrees around the longitudinal axis when expanded so that side branch vessels are not occluded by the cover.
21. The device of claim 12, further comprising:
a source of energy coupled to at least the lateral extension.
22. The device of claim 21, wherein:
the source of energy is RF energy.
23. The device of claim 21, wherein:
the cover does not conduct the energy when the lateral extension conducts energy from the source of energy.
24. The device of claim 12, wherein:
the cover comprises a mesh.
25. The device of claim 12, further comprising:
a delivery catheter having at least one lumen; and
a first manipulator extending through the at least one lumen and releasably coupled to the lateral extension.
26. The device of claim 12, further comprising:
a second manipulator releasably coupled to the cover.
27. A method of treating an aneurysm, comprising the steps of:
providing a cover which is positioned around an expandable element in a collapsed position, the cover being covered by a sheath;
advancing the cover to an aneurysm in a patient with the cover in the collapsed position;
withdrawing the sheath to expose the cover;
expanding the expandable member thereby expanding the cover, the cover expanding to an expanded condition, the cover being positioned over a neck of the aneurysm.
28. The method of claim 27, wherein:
the providing step is carried out with the cover being wrapped around the expandable element without creating folds when collapsed.
29. The method of claim 27, wherein:
the expanding step is carried out with the cover engaging a wall of the parental vessel around the neck of the aneurysm.
30. The method of claim 27, wherein:
the expanding step is carried out with the cover being attached to the wall.
31. The method of claim 30, wherein:
the providing step is carried out with an adhesive positioned on an outer surface of the cover and protected by the sheath during the advancing step.
32. The method of claim 27, wherein:
the expanding step is carried out with the cover extending no more than half the circumference of the vessel.
33. The method of claim 27, wherein:
the expanding step is carried out with the cover extending no more than one third the circumference of the vessel.
34. The method of claim 27, wherein:
the providing step is carried out with the cover having a metallic frame structure and an impermeable portion mounted to the frame, the impermeable portion being positioned to cover the neck of the aneurysm after the inflating step.
35. The method of claims 27, wherein:
the providing step is carried out with the sheath being folded over itself at a distal end; and
the exposing step is carried out with the sheath being pulled back over itself.
36. The method of claim 27, wherein:
the providing step is carried out with the sheath comprising PTFE.
37. The method of claim 27, wherein:
the cover is mounted to a delivery catheter, the delivery catheter having a single lumen; and
the advancing step is carried out with the device being advanced over a guidewire extending through the single lumen.
38. A device for treating an aneurysm, comprising:
a cover for covering a neck of an aneurysm
a delivery catheter having an expandable element and a sheath, the cover being mounted around the expandable element, the sheath being retractable and overlying the cover thereby trapping the cover between the sheath and expandable element, the sheath being movable to a position in which the cover is exposed to permit expansion of the expandable element and the cover.
39. The device of claim 38, wherein:
the delivery catheter has a longitudinal axis; and
the cover is wrapped around the balloon in the collapsed position without folds.
40. The device of claim 38, further comprising:
an adhesive on an outer surface of the cover.
41. The method of claim 38, wherein:
the cover has a metallic frame and an impermeable portion mounted to the frame which covers the neck of the aneurysm.
42. The method of claims 38, wherein:
the sheath is folded over itself at a distal end, the sheath being pulled back when exposing the cover.
43. The method of claim 38, wherein:
the sheath comprises PTFE.
44. The method of claim 38, wherein:
the delivery catheter has a single lumen which receives a guidewire;
45. A device for treating an aneurysm, comprising:
a proximal hub;
a distal hub; and
a plurality of filaments extending between the proximal and distal hubs, the filaments biasing the proximal and distal hubs towards one another when moving from a collapsed position to an expanded position.
46. The device of claim 45, wherein:
the plurality of filaments are 2-16 filaments.
47. The device of claim 45, wherein:
the plurality of filaments form a generally concave surface which covers a neck of an aneurysm when positioned in the aneurysm.
48. The device of claim 45, wherein:
the plurality of filaments form a generally convex surface opposite the concave surface.
49. The device of claim 45, further comprising:
a catheter having a lumen; and
a manipulator extending through the lumen and contacting the proximal hub.
50. The device of claim 45, further comprising:
a source of power coupled to the manipulator.
51. The device of claim 50, wherein:
the source of power is an RF generator.
52. A device for filling an aneurysm, comprising:
a catheter having a lumen;
a plurality of filaments each having a proximal end and a distal end, the plurality of filaments being coupled together at the proximal ends and each of the filaments extending to a free end at the distal end, the plurality of filaments being in a collapsed condition when positioned in the lumen of the catheter, the plurality of filaments expanding to occupy a space in an aneurysm when advanced out of the lumen in the catheter.
53. The device of claim 52, wherein:
the plurality of filaments are in a straightened configuration when collapsed within the catheter.
54. The device of claim 52, wherein:
each of the plurality of filaments forms a coil in the expanded position.
55. The device of claim 54, wherein:
the coils formed by the plurality of filaments each have a central axis with the central axes of the coils generally lying in a plane.
56. The device of claim 54, wherein:
the coils formed by the plurality of filaments each have a central axis with the central axis of the coils being angled relative to one another by about 90-120 degrees.
57. The device of claim 52, wherein:
the plurality of filaments are 2-4 filaments.
58. A method of treating a cerebral aneurysm, comprising the steps of:
providing an expandable structure movable from a collapsed shape to an expanded shape;
introducing the expandable structure into a blood vessel of a patient;
advancing the expandable structure through the patient's vasculature to a cerebral aneurysm while the expandable structure is in the collapsed position;
moving the expandable structure into the cerebral aneurysm;
expanding the expandable structure to the expanded position in the cerebral aneurysm;
shrinking the wall of the aneurysm; and
leaving the expandable structure in the aneurysm after the shrinking step.
US10/729,432 1999-06-02 2003-12-04 Devices and methods for treating vascular malformations Abandoned US20040181253A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/729,432 US20040181253A1 (en) 1999-06-02 2003-12-04 Devices and methods for treating vascular malformations
US12/961,471 US20110082491A1 (en) 1999-06-02 2010-12-06 Devices and methods for treating vascular malformations

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/324,359 US6375668B1 (en) 1999-06-02 1999-06-02 Devices and methods for treating vascular malformations
US09/695,637 US6746468B1 (en) 1999-06-02 2000-10-24 Devices and methods for treating vascular malformations
US10/729,432 US20040181253A1 (en) 1999-06-02 2003-12-04 Devices and methods for treating vascular malformations

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/695,637 Continuation US6746468B1 (en) 1999-06-02 2000-10-24 Devices and methods for treating vascular malformations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/961,471 Continuation US20110082491A1 (en) 1999-06-02 2010-12-06 Devices and methods for treating vascular malformations

Publications (1)

Publication Number Publication Date
US20040181253A1 true US20040181253A1 (en) 2004-09-16

Family

ID=23263261

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/324,359 Expired - Lifetime US6375668B1 (en) 1999-06-02 1999-06-02 Devices and methods for treating vascular malformations
US09/695,637 Expired - Lifetime US6746468B1 (en) 1999-06-02 2000-10-24 Devices and methods for treating vascular malformations
US10/066,333 Abandoned US20020143349A1 (en) 1999-06-02 2002-01-30 Devices and methods for treating vascular malformations
US10/729,432 Abandoned US20040181253A1 (en) 1999-06-02 2003-12-04 Devices and methods for treating vascular malformations
US12/961,471 Abandoned US20110082491A1 (en) 1999-06-02 2010-12-06 Devices and methods for treating vascular malformations

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/324,359 Expired - Lifetime US6375668B1 (en) 1999-06-02 1999-06-02 Devices and methods for treating vascular malformations
US09/695,637 Expired - Lifetime US6746468B1 (en) 1999-06-02 2000-10-24 Devices and methods for treating vascular malformations
US10/066,333 Abandoned US20020143349A1 (en) 1999-06-02 2002-01-30 Devices and methods for treating vascular malformations

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/961,471 Abandoned US20110082491A1 (en) 1999-06-02 2010-12-06 Devices and methods for treating vascular malformations

Country Status (5)

Country Link
US (5) US6375668B1 (en)
EP (1) EP1198270A4 (en)
AU (2) AU773570B2 (en)
CA (1) CA2375660A1 (en)
WO (1) WO2000072909A1 (en)

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050049681A1 (en) * 2003-05-19 2005-03-03 Secant Medical, Llc Tissue distention device and related methods for therapeutic intervention
EP1920724A1 (en) * 2006-11-07 2008-05-14 Medtronic Vascular, Inc. Cutting radio frequency catheter for creating fenestrations in graft cloth
WO2008157507A2 (en) * 2007-06-15 2008-12-24 Nfocus Neuromedical, Inc. Blood flow diverters and aneurysm covering devices
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US7803395B2 (en) 2003-05-15 2010-09-28 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US20110046658A1 (en) * 2008-05-01 2011-02-24 Aneuclose Llc Aneurysm occlusion device
US20120271337A1 (en) * 2007-04-16 2012-10-25 Hans-Reiner Figulla Occluder For Occluding an Atrial Appendage and Production Process Therefor
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US8663301B2 (en) 2007-12-11 2014-03-04 Cornell University Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US8728141B2 (en) 2007-12-11 2014-05-20 Cornell University Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen
US8747597B2 (en) 2008-04-21 2014-06-10 Covidien Lp Methods for making braid-ball occlusion devices
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US8956475B2 (en) 2007-12-11 2015-02-17 Howard Riina Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US8968382B2 (en) 2007-12-11 2015-03-03 Cornell University Method and apparatus for restricting flow through an opening in the side wall
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US9095342B2 (en) 2009-11-09 2015-08-04 Covidien Lp Braid ball embolic device features
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11648013B2 (en) 2016-03-11 2023-05-16 Cerus Endovascular Limited Occlusion device
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device

Families Citing this family (445)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569066B2 (en) * 1997-07-10 2009-08-04 Boston Scientific Scimed, Inc. Methods and devices for the treatment of aneurysms
US7410482B2 (en) 1998-09-04 2008-08-12 Boston Scientific-Scimed, Inc. Detachable aneurysm neck bridge
EP1109499B1 (en) 1998-09-04 2007-08-15 Boston Scientific Limited Detachable aneurysm neck closure patch
US8715156B2 (en) 1998-10-09 2014-05-06 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence function
US6685627B2 (en) 1998-10-09 2004-02-03 Swaminathan Jayaraman Modification of properties and geometry of heart tissue to influence heart function
US7044134B2 (en) * 1999-11-08 2006-05-16 Ev3 Sunnyvale, Inc Method of implanting a device in the left atrial appendage
AU5179900A (en) * 1999-06-02 2000-12-18 Sethel Interventional, Inc. Intracorporeal occlusive device
US20050154370A1 (en) 1999-10-29 2005-07-14 Medtronic, Inc. Methods and systems for providing therapies into the pericardial space
US6613062B1 (en) * 1999-10-29 2003-09-02 Medtronic, Inc. Method and apparatus for providing intra-pericardial access
US7758521B2 (en) * 1999-10-29 2010-07-20 Medtronic, Inc. Methods and systems for accessing the pericardial space
US20030093104A1 (en) * 1999-10-29 2003-05-15 Bonner Matthew D. Methods and apparatus for providing intra-pericardial access
US6331184B1 (en) * 1999-12-10 2001-12-18 Scimed Life Systems, Inc. Detachable covering for an implantable medical device
JP4926359B2 (en) 2000-05-03 2012-05-09 シー・アール・バード・インコーポレーテッド Apparatus and method for mapping and cauterization in electrophysiological procedures
US6824545B2 (en) 2000-06-29 2004-11-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US8298257B2 (en) * 2000-06-29 2012-10-30 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7727242B2 (en) 2000-06-29 2010-06-01 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7766921B2 (en) * 2000-06-29 2010-08-03 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7727243B2 (en) 2000-06-29 2010-06-01 Concentric Medical., Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7285126B2 (en) * 2000-06-29 2007-10-23 Concentric Medical, Inc. Systems, methods and devices for removing obstructions from a blood vessel
US7077836B2 (en) * 2000-07-21 2006-07-18 Vein Rx, Inc. Methods and apparatus for sclerosing the wall of a varicose vein
US6589265B1 (en) * 2000-10-31 2003-07-08 Endovascular Technologies, Inc. Intrasaccular embolic device
GB0030794D0 (en) * 2000-12-16 2001-01-31 Hudson John O Medical device and use thereof
EP1383426B1 (en) * 2001-04-27 2008-12-24 C.R. Bard, Inc. Catheter for three dimensional mapping of electrical activity in blood vessels
US7727229B2 (en) * 2001-05-01 2010-06-01 C.R. Bard, Inc. Method and apparatus for altering conduction properties in the heart and in adjacent vessels
US6855153B2 (en) 2001-05-01 2005-02-15 Vahid Saadat Embolic balloon
CA2447377C (en) * 2001-05-17 2008-11-25 Kiyoshi Hashiba Intragastric device for treating obesity
US20030032976A1 (en) * 2001-05-21 2003-02-13 Boucek Mark M. Catheter deployed partial occlusion devices and methods
US6921410B2 (en) * 2001-05-29 2005-07-26 Scimed Life Systems, Inc. Injection molded vaso-occlusive elements
US20030181927A1 (en) * 2001-06-21 2003-09-25 Wallace Michael P. Aneurysm neck obstruction device
US6454780B1 (en) * 2001-06-21 2002-09-24 Scimed Life Systems, Inc. Aneurysm neck obstruction device
US8252040B2 (en) * 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US6802851B2 (en) * 2001-09-20 2004-10-12 Gordia Neurovascular, Inc. Stent aneurysm embolization method using collapsible member and embolic coils
US7912554B2 (en) * 2001-09-26 2011-03-22 Medtronic Cryocath Lp Method for treatment of aneurysms
US7033389B2 (en) * 2001-10-16 2006-04-25 Scimed Life Systems, Inc. Tubular prosthesis for external agent delivery
US20040116998A1 (en) * 2001-11-19 2004-06-17 Raimund Erbel Endovascular prosthesis
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US7363927B2 (en) * 2002-02-26 2008-04-29 Arvik Enterprises, Llc Removable blood vessel occlusion device
US6638257B2 (en) * 2002-03-01 2003-10-28 Aga Medical Corporation Intravascular flow restrictor
US7278430B2 (en) * 2002-03-01 2007-10-09 Arvik Enterprises, Llc Blood vessel occlusion device
US7695488B2 (en) * 2002-03-27 2010-04-13 Boston Scientific Scimed, Inc. Expandable body cavity liner device
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US20030195553A1 (en) * 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US6960215B2 (en) * 2002-05-08 2005-11-01 Boston Scientific Scimed, Inc. Tactical detachable anatomic containment device and therapeutic treatment system
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US7058456B2 (en) * 2002-08-09 2006-06-06 Concentric Medical, Inc. Methods and devices for changing the shape of a medical device
US20040034386A1 (en) * 2002-08-19 2004-02-19 Michael Fulton Aneurysm stent
US8075585B2 (en) * 2002-08-29 2011-12-13 Stryker Corporation Device and method for treatment of a vascular defect
US7481821B2 (en) 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
FR2847151B1 (en) * 2002-11-15 2005-01-21 Claude Mialhe OCCLUSIVE DEVICE WITH MEDICAL OR SURGICAL DESTINATION
US7229454B2 (en) * 2003-01-07 2007-06-12 Boston Scientific Scimed, Inc. Occlusive cinching devices and methods of use
US7744583B2 (en) * 2003-02-03 2010-06-29 Boston Scientific Scimed Systems and methods of de-endothelialization
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US7972330B2 (en) 2003-03-27 2011-07-05 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US8021362B2 (en) * 2003-03-27 2011-09-20 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US7186251B2 (en) 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7165552B2 (en) * 2003-03-27 2007-01-23 Cierra, Inc. Methods and apparatus for treatment of patent foramen ovale
US6939348B2 (en) * 2003-03-27 2005-09-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
WO2004087235A2 (en) * 2003-03-27 2004-10-14 Cierra, Inc. Methods and apparatus for treatment of patent foramen ovale
US7293562B2 (en) * 2003-03-27 2007-11-13 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
ES2417815T3 (en) * 2003-03-28 2013-08-09 C. R. Bard, Inc. Braided mesh catheter
EP1617766B1 (en) * 2003-04-22 2015-08-05 Patrick Leahy A device for use in parietal surgery
US7182744B2 (en) * 2003-04-25 2007-02-27 Medtronic Vascular Method and apparatus for aneurismal treatment
US7311701B2 (en) * 2003-06-10 2007-12-25 Cierra, Inc. Methods and apparatus for non-invasively treating atrial fibrillation using high intensity focused ultrasound
WO2005006990A2 (en) 2003-07-14 2005-01-27 Nmt Medical, Inc. Tubular patent foramen ovale (pfo) closure device with catch system
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US20050015110A1 (en) * 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
US7309345B2 (en) * 2003-07-25 2007-12-18 Boston Scientific-Scimed, Inc. Method and system for delivering an implant utilizing a lumen reducing member
DE202004021944U1 (en) 2003-09-12 2013-07-16 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
US20050085836A1 (en) * 2003-09-12 2005-04-21 Jean Raymond Methods and devices for endothelial denudation to prevent recanalization after embolization
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
US20110208233A1 (en) * 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
US20050165480A1 (en) * 2004-01-23 2005-07-28 Maybelle Jordan Endovascular treatment devices and methods
US20050187565A1 (en) 2004-02-20 2005-08-25 Baker Steve G. Tissue fixation devices and a transoral endoscopic gastroesophageal flap valve restoration device and assembly using same
US7632287B2 (en) * 2004-02-20 2009-12-15 Endogastric Solutions, Inc. Tissue fixation devices and assemblies for deploying the same
US9039724B2 (en) 2004-03-19 2015-05-26 Aga Medical Corporation Device for occluding vascular defects
US8747453B2 (en) 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US8777974B2 (en) 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US8398670B2 (en) * 2004-03-19 2013-03-19 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US8425539B2 (en) 2004-04-12 2013-04-23 Xlumena, Inc. Luminal structure anchoring devices and methods
US8249685B2 (en) 2004-05-17 2012-08-21 C.R. Bard, Inc. Method and apparatus for mapping and/or ablation of cardiac tissue
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8147534B2 (en) 2005-05-25 2012-04-03 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US7678135B2 (en) * 2004-06-09 2010-03-16 Usgi Medical, Inc. Compressible tissue anchor assemblies
US7367975B2 (en) 2004-06-21 2008-05-06 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US9974607B2 (en) 2006-10-18 2018-05-22 Vessix Vascular, Inc. Inducing desirable temperature effects on body tissue
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
WO2006034153A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film metallic devices for plugging aneurysms or vessels
US8444668B2 (en) * 2004-09-17 2013-05-21 DePuy Synthes Products, LLC Expandable vascular occlusion device
WO2006034166A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film metallic devices for plugging aneurysms or vessels
DE502004010411D1 (en) 2004-09-22 2009-12-31 Dendron Gmbh DEVICE FOR IMPLANTING MICROWAVES
ES2321300T3 (en) 2004-09-22 2009-06-04 Dendron Gmbh MEDICAL IMPLANT
CA2581087C (en) * 2004-09-24 2013-11-19 Ingeneus Inc. Genomic assay
US8764848B2 (en) * 2004-09-24 2014-07-01 W.L. Gore & Associates, Inc. Occluder device double securement system for delivery/recovery of such occluder device
US7753907B2 (en) * 2004-10-29 2010-07-13 Boston Scientific Scimed, Inc. Medical device systems and methods
US8771294B2 (en) * 2004-11-26 2014-07-08 Biomerix Corporation Aneurysm treatment devices and methods
US20060116697A1 (en) 2004-11-30 2006-06-01 Esophyx, Inc. Flexible transoral endoscopic gastroesophageal flap valve restoration device and method
US9545300B2 (en) * 2004-12-22 2017-01-17 W. L. Gore & Associates, Inc. Filament-wound implantable devices
US7722529B2 (en) * 2004-12-28 2010-05-25 Palo Alto Investors Expandable vessel harness for treating vessel aneurysms
US20060155323A1 (en) * 2005-01-07 2006-07-13 Porter Stephen C Intra-aneurysm devices
WO2006078988A2 (en) * 2005-01-21 2006-07-27 Loubert Suddaby Aneurysm repair method and apparatus
US20060167481A1 (en) 2005-01-25 2006-07-27 Esophyx, Inc. Slitted tissue fixation devices and assemblies for deploying the same
TW200635566A (en) 2005-01-25 2006-10-16 Vnus Med Tech Inc Structures for permanent occlusion of a hollow anatomical structure
US20060175543A1 (en) * 2005-02-08 2006-08-10 John Elefteriades Intra-thecal catheter and method for cooling the spinal cord
US20060259074A1 (en) * 2005-02-22 2006-11-16 Brian Kelleher Methods and devices for anchoring to soft tissue
US20060206198A1 (en) * 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices and methods
US20060206199A1 (en) * 2005-03-12 2006-09-14 Churchwell Stacey D Aneurysm treatment devices
EP1865870B8 (en) 2005-03-28 2012-04-04 Vessix Vascular, Inc. Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues
CA2599310C (en) * 2005-04-11 2013-12-10 Cierra, Inc. Methods and apparatus to achieve a closure of a layered tissue defect
EP1871241B1 (en) * 2005-04-22 2012-12-19 Rex Medical, L.P. Closure device for left atrial appendage
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8298291B2 (en) 2005-05-26 2012-10-30 Usgi Medical, Inc. Methods and apparatus for securing and deploying tissue anchors
US9585651B2 (en) 2005-05-26 2017-03-07 Usgi Medical, Inc. Methods and apparatus for securing and deploying tissue anchors
US8784437B2 (en) 2005-06-09 2014-07-22 Xlumena, Inc. Methods and devices for endosonography-guided fundoplexy
US8777967B2 (en) 2005-06-09 2014-07-15 Xlumena, Inc. Methods and devices for anchoring to tissue
US20070005082A1 (en) 2005-06-29 2007-01-04 Esophyx, Inc. Apparatus and method for manipulating stomach tissue and treating gastroesophageal reflux disease
US20070038232A1 (en) 2005-08-12 2007-02-15 Kraemer Stefan J M Apparatus and method for securing the stomach to the diaphragm for use, for example, in treating hiatal hernias and gastroesophageal reflux disease
US20070078480A1 (en) * 2005-10-04 2007-04-05 Boston Scientific Scimed, Inc. Self-expanding biodegradable or water-soluble vaso-occlusive devices
US20070088373A1 (en) 2005-10-18 2007-04-19 Endogastric Solutions, Inc. Invaginator for gastroesophageal flap valve restoration device
AU2006304660B2 (en) * 2005-10-19 2013-10-24 Pulsar Vascular, Inc. Methods and systems for endovascularly clipping and repairing lumen and tissue defects
US8545530B2 (en) * 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
EP1945152A4 (en) * 2005-11-09 2010-01-06 Merlin Md Pte Ltd Medical device with non-circumferential surface portion
US9161754B2 (en) 2012-12-14 2015-10-20 Endogastric Solutions, Inc. Apparatus and method for concurrently forming a gastroesophageal valve and tightening the lower esophageal sphincter
EP1986568B1 (en) 2006-02-03 2017-04-05 Covidien LP Methods and devices for restoring blood flow within blocked vasculature
US20070225738A1 (en) * 2006-03-24 2007-09-27 Cook Incorporated Aneurysm coil and method of assembly
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
WO2007121405A2 (en) 2006-04-17 2007-10-25 Micro Therapeutics, Inc. System and method for mechanically positioning intravascular implants
US9017361B2 (en) 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US8690935B2 (en) * 2006-04-28 2014-04-08 DePuy Synthes Products, LLC Stent delivery system with threaded engagement and method
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
WO2007134266A2 (en) 2006-05-12 2007-11-22 Electroformed Stents, Inc. Exclusion device and system for delivery
GB0700553D0 (en) 2007-01-11 2007-02-21 Emcision Ltd Vessel sealing device
WO2007140797A1 (en) * 2006-06-02 2007-12-13 Occlutech Gmbh Occlusion instrument for closing a cardiac auricle
EP2056746A2 (en) * 2006-08-17 2009-05-13 NFOCUS Neuromedical Inc. Aneurysm covering devices and delivery devices
EP2056747A2 (en) * 2006-08-17 2009-05-13 NFOCUS Neuromedical Inc. Isolation devices for the treatment of aneurysms
EP1891902A1 (en) * 2006-08-22 2008-02-27 Carag AG Occluding device
US20080167637A1 (en) * 2006-10-13 2008-07-10 Sonny Yamasaki Method and apparatus for aneurismal treatment
CA2666663C (en) 2006-10-18 2016-02-09 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
EP2455036B1 (en) 2006-10-18 2015-07-15 Vessix Vascular, Inc. Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
JP2010508910A (en) * 2006-11-02 2010-03-25 アール. ショーン パクバズ, Devices and methods for accessing and treating aneurysms
US8372114B2 (en) 2006-11-13 2013-02-12 Electroformed Stents, Inc. Over-the-wire exclusion device and system for delivery
US20080140069A1 (en) * 2006-12-07 2008-06-12 Cierra, Inc. Multi-electrode apparatus for tissue welding and ablation
US8187315B1 (en) 2006-12-08 2012-05-29 Cardica, Inc. Partial stent for treatment of a vascular aneurysm
WO2008085994A2 (en) 2007-01-08 2008-07-17 Endogastric Solutions Connected fasteners, delivery device and method
US10463886B2 (en) * 2007-02-22 2019-11-05 Ramot At Tel-Aviv University Ltd. Treating weakened vessel wall such as vulnerable plaque or aneurysms
WO2008112435A2 (en) 2007-03-13 2008-09-18 Micro Therapeutics, Inc. An implant including a coil and a stretch-resistant member
KR20100015521A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant, a mandrel, and a method of forming an implant
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
US8535334B2 (en) 2007-04-17 2013-09-17 Lazarus Effect, Inc. Complex wire formed devices
US10076346B2 (en) 2007-04-17 2018-09-18 Covidien Lp Complex wire formed devices
US11202646B2 (en) 2007-04-17 2021-12-21 Covidien Lp Articulating retrieval devices
US10064635B2 (en) 2007-04-17 2018-09-04 Covidien Lp Articulating retrieval devices
US8496653B2 (en) 2007-04-23 2013-07-30 Boston Scientific Scimed, Inc. Thrombus removal
WO2008136999A1 (en) * 2007-04-30 2008-11-13 The Board Of Trustees Of The Leland Stanford Junior University Prevention of displacement of prosthetic devices within aneurysms
US20110022149A1 (en) 2007-06-04 2011-01-27 Cox Brian J Methods and devices for treatment of vascular defects
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド Self-expanding prosthesis
US8034061B2 (en) 2007-07-12 2011-10-11 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
CA2699259A1 (en) * 2007-09-11 2009-03-19 Nfocus Neuromedical Inc. Aneurysm cover device for embolic delivery and retention
US9034007B2 (en) 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US8926680B2 (en) 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US9220522B2 (en) 2007-10-17 2015-12-29 Covidien Lp Embolus removal systems with baskets
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US10123803B2 (en) 2007-10-17 2018-11-13 Covidien Lp Methods of managing neurovascular obstructions
US8066757B2 (en) 2007-10-17 2011-11-29 Mindframe, Inc. Blood flow restoration and thrombus management methods
US8585713B2 (en) 2007-10-17 2013-11-19 Covidien Lp Expandable tip assembly for thrombus management
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US9198687B2 (en) 2007-10-17 2015-12-01 Covidien Lp Acute stroke revascularization/recanalization systems processes and products thereby
US20090163851A1 (en) * 2007-12-19 2009-06-25 Holloway Kenneth A Occlusive material removal device having selectively variable stiffness
JP5366974B2 (en) 2007-12-21 2013-12-11 マイクロベンション インコーポレイテッド System and method for determining the position of a separation zone of a separable implant
WO2009086214A1 (en) 2007-12-21 2009-07-09 Microvention, Inc. A system and method of detecting implant detachment
US8545526B2 (en) * 2007-12-26 2013-10-01 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US9743918B2 (en) * 2008-01-18 2017-08-29 St. Jude Medical, Cardiology Division, Inc. Percutaneous catheter directed intravascular occlusion device
US8235988B2 (en) 2008-01-24 2012-08-07 Coherex Medical, Inc. Systems and methods for reduction of atrial fibrillation
AU2009217354B2 (en) 2008-02-22 2013-10-10 Covidien Lp Methods and apparatus for flow restoration
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
CN101977650A (en) 2008-04-11 2011-02-16 曼德弗雷姆公司 Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
CA3048277C (en) * 2008-05-02 2022-06-21 Sequent Medical Inc. Filamentary devices for treatment of vascular defects
US8454632B2 (en) 2008-05-12 2013-06-04 Xlumena, Inc. Tissue anchor for securing tissue layers
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
JP5791048B2 (en) * 2008-09-05 2015-10-07 パルサー バスキュラー インコーポレイテッド System and method for supporting or occluding a physiological opening or cavity
WO2010056745A1 (en) 2008-11-17 2010-05-20 Minnow Medical, Inc. Selective accumulation of energy with or without knowledge of tissue topography
US20110029050A1 (en) * 2008-11-18 2011-02-03 John Elefteriades Intra-ventricular brain cooling catheter
AU2009327376B2 (en) * 2008-12-19 2013-08-22 Covidien Lp Method and apparatus for storage and/or introduction of implant for hollow anatomical structure
US10702275B2 (en) * 2009-02-18 2020-07-07 St. Jude Medical Cardiology Division, Inc. Medical device with stiffener wire for occluding vascular defects
EP2403583B1 (en) 2009-03-06 2016-10-19 Lazarus Effect, Inc. Retrieval systems
US8906037B2 (en) 2009-03-18 2014-12-09 Endogastric Solutions, Inc. Methods and devices for forming a tissue fold
US9364259B2 (en) 2009-04-21 2016-06-14 Xlumena, Inc. System and method for delivering expanding trocar through a sheath
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
WO2010134914A1 (en) * 2009-05-20 2010-11-25 University Of Miami Spherical helix embolic coils for the treatment of cerebral aneurysms
EP2434961B1 (en) 2009-05-29 2015-01-14 Xlumena, Inc. Apparatus and method for deploying stent across adjacent tissue layers
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US8956389B2 (en) 2009-06-22 2015-02-17 W. L. Gore & Associates, Inc. Sealing device and delivery system
CN102762156B (en) 2009-09-04 2015-06-24 帕尔萨维斯库勒公司 Systems and methods for enclosing an anatomical opening
US20110152993A1 (en) * 2009-11-05 2011-06-23 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
US9814562B2 (en) 2009-11-09 2017-11-14 Covidien Lp Interference-relief type delivery detachment systems
US20110137334A1 (en) * 2009-12-04 2011-06-09 Boston Scientific Scimed, Inc. Electroactively Deployed Filter Device
US8801748B2 (en) 2010-01-22 2014-08-12 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
JP4499831B1 (en) * 2010-01-22 2010-07-07 規方 田熊 Aneurysm embolizer
WO2011098633A1 (en) * 2010-02-12 2011-08-18 Vasuclip, S.L. Device for aneurysm occlusion and a treatment method
EP2539012B1 (en) 2010-02-23 2018-01-24 Covidien LP Devices for vascular recanalization
KR20130108067A (en) 2010-04-09 2013-10-02 베식스 바스큘라 인코포레이티드 Power generating and control apparatus for the treatment of tissue
EP4039203A1 (en) 2010-04-13 2022-08-10 Mivi Neuroscience, Inc. Embolectomy devices for treatment of acute ischemic stroke condition
US9561125B2 (en) 2010-04-14 2017-02-07 Microvention, Inc. Implant delivery device
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US8876870B2 (en) 2010-04-27 2014-11-04 Adnan Iqbal Qureshi Intraspinal device deployed through percutaneous approach into subarachnoid or intradural space of vertebral canal to protect spinal cord from external compression
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
WO2012003317A1 (en) 2010-07-02 2012-01-05 Alex Javois Left atrial appendage occlusion device
WO2012009675A2 (en) 2010-07-15 2012-01-19 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US8876849B2 (en) 2010-07-20 2014-11-04 Cook Medical Technologies Llc False lumen occluder
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
WO2012023980A1 (en) 2010-08-17 2012-02-23 St. Jude Medical, Inc. Sleeve for facilitating movement of a transfemoral catheter
ES2734888T3 (en) * 2010-09-06 2019-12-12 Occlutech Holding Ag Device for closing openings or cavities in blood vessels
EP3354210B1 (en) 2010-09-10 2022-10-26 Covidien LP Devices for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
AU2011302639B2 (en) 2010-09-17 2014-07-31 St. Jude Medical, Cardiology Division, Inc. Retainers for transcatheter heart valve delivery systems
US9962275B2 (en) * 2010-10-07 2018-05-08 Randy Louis Werneth Temporary gastric device (TGD) and method of use
US9463036B2 (en) 2010-10-22 2016-10-11 Neuravi Limited Clot engagement and removal system
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
CN103237526B (en) 2010-12-06 2015-12-02 科维蒂恩有限合伙公司 Vascular remodeling device
US9867725B2 (en) 2010-12-13 2018-01-16 Microvention, Inc. Stent
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US11484318B2 (en) 2011-01-17 2022-11-01 Artio Medical, Inc. Expandable body device and method of use
KR102139383B1 (en) 2011-01-17 2020-07-30 메타랙티브 메디컬, 인크. Detachable metal balloon delivery device and method
US9220561B2 (en) 2011-01-19 2015-12-29 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
US11259824B2 (en) 2011-03-09 2022-03-01 Neuravi Limited Clot retrieval device for removing occlusive clot from a blood vessel
WO2012120490A2 (en) 2011-03-09 2012-09-13 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
WO2012161875A1 (en) 2011-04-08 2012-11-29 Tyco Healthcare Group Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
WO2012148969A2 (en) 2011-04-25 2012-11-01 Brian Kelly Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
CA2835427A1 (en) 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
BR112013030183A2 (en) 2011-05-23 2017-12-05 Lazarus Effect Inc interventional medical device for recovering and securing an obstruction within a vessel lumen, method of securing an obstruction within a vessel, method of preparing a retrieval device, medical device retrieval system, for securing an obstruction within a lumen and for use with a catheter configured to be navigated through the vasculature, interventional medical device to secure a retrieval device having one or more obstructions located therein for removal of a body and stent retrieval device to expand against one or more occlusive bodies in a vasculature
CA2837717C (en) 2011-06-03 2019-07-09 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
EP2713904B1 (en) 2011-06-03 2018-01-10 Pulsar Vascular, Inc. Aneurysm devices with additional anchoring mechanisms and associated systems
CA2837879C (en) * 2011-06-03 2019-11-12 Reverse Medical Corporation Embolic implant and method of use
US8764787B2 (en) * 2011-06-17 2014-07-01 Aga Medical Corporation Occlusion device and associated deployment method
WO2013013156A2 (en) 2011-07-20 2013-01-24 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
JP6106669B2 (en) 2011-07-22 2017-04-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. A neuromodulation system having a neuromodulation element that can be placed in a helical guide
US9370422B2 (en) 2011-07-28 2016-06-21 St. Jude Medical, Inc. Expandable radiopaque marker for transcatheter aortic valve implantation
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
US8915929B2 (en) 2011-09-09 2014-12-23 Endogastric Solutions, Inc. Methods and devices for manipulating and fastening tissue
US9572571B2 (en) 2011-09-09 2017-02-21 Endogastric Solutions, Inc. Methods and devices for manipulating and fastening tissue
US9955957B2 (en) 2011-09-09 2018-05-01 Endogastric Solutions, Inc. Methods and devices for manipulating and fastening tissue
US8945171B2 (en) 2011-09-29 2015-02-03 Covidien Lp Delivery system for implantable devices
US8795313B2 (en) 2011-09-29 2014-08-05 Covidien Lp Device detachment systems with indicators
ES2809210T3 (en) 2011-10-05 2021-03-03 Pulsar Vascular Inc Systems and devices for wrapping an anatomical opening
EP2765942B1 (en) 2011-10-10 2016-02-24 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
EP2765940B1 (en) 2011-10-11 2015-08-26 Boston Scientific Scimed, Inc. Off-wall electrode device for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
EP2768563B1 (en) 2011-10-18 2016-11-09 Boston Scientific Scimed, Inc. Deflectable medical devices
WO2013070724A1 (en) 2011-11-08 2013-05-16 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
EP2779929A1 (en) 2011-11-15 2014-09-24 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9579104B2 (en) * 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
WO2013096920A1 (en) 2011-12-23 2013-06-27 Vessix Vascular, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
WO2013101452A1 (en) 2011-12-28 2013-07-04 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
JP2015509752A (en) * 2012-01-06 2015-04-02 インセプタス メディカル, エルエルシー Expandable occlusive device and method of use
AU2012366236B2 (en) 2012-01-17 2017-10-12 Artio Medical, Inc. Expandable body device and method of use
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9339275B2 (en) 2012-01-26 2016-05-17 Endoshape, Inc. Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control
JP2013154089A (en) * 2012-01-31 2013-08-15 Terumo Corp Aneurysm treatment device and aneurysm treatment method
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9408662B2 (en) 2012-05-07 2016-08-09 Cook Medical Technologies Llc Sphincterotome having expandable tines
US10660703B2 (en) 2012-05-08 2020-05-26 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US9259229B2 (en) 2012-05-10 2016-02-16 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices
JP6360042B2 (en) 2012-05-17 2018-07-18 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Method and device for access across adjacent tissue layers
US9480561B2 (en) 2012-06-26 2016-11-01 St. Jude Medical, Cardiology Division, Inc. Apparatus and method for aortic protection and TAVI planar alignment
US9918837B2 (en) 2012-06-29 2018-03-20 St. Jude Medical, Cardiology Division, Inc. System to assist in the release of a collapsible stent from a delivery device
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US10321946B2 (en) 2012-08-24 2019-06-18 Boston Scientific Scimed, Inc. Renal nerve modulation devices with weeping RF ablation balloons
CN104780859B (en) 2012-09-17 2017-07-25 波士顿科学西美德公司 Self-positioning electrode system and method for renal regulation
US10549127B2 (en) 2012-09-21 2020-02-04 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
CN104869930B (en) 2012-10-10 2020-12-25 波士顿科学国际有限公司 Renal neuromodulation apparatus and methods
US9186267B2 (en) 2012-10-31 2015-11-17 Covidien Lp Wing bifurcation reconstruction device
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
AU2014218701A1 (en) 2013-02-21 2015-09-10 Xlumena, Inc. Devices and methods for forming an anastomosis
US10028746B2 (en) * 2013-03-08 2018-07-24 St. Jude Medical, Cardiology Division, Inc. Medical device for treating a target site
US10973523B2 (en) 2013-03-08 2021-04-13 Aga Medical Corporation Medical device for treating a target site
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9662119B2 (en) * 2013-03-13 2017-05-30 Lawrence Livermore National Security, Llc Shape-memory polymer foam device for treating aneurysms
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US9642635B2 (en) 2013-03-13 2017-05-09 Neuravi Limited Clot removal device
US20140277091A1 (en) * 2013-03-14 2014-09-18 Cook Medical Technologies Llc Detachable delivery device
SI2967610T1 (en) 2013-03-14 2019-07-31 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
TR201901830T4 (en) 2013-03-14 2019-03-21 Neuravi Ltd Devices and methods for the removal of acute blockages from blood vessels.
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
US8715315B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment systems
EP2967576B1 (en) 2013-03-15 2023-02-15 Covidien LP Delivery and detachment mechanisms for vascular implants
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
EP2967578A2 (en) 2013-03-15 2016-01-20 Covidien LP Occlusive implant structures
WO2014149690A2 (en) 2013-03-15 2014-09-25 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
EP2967734B1 (en) 2013-03-15 2019-05-15 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
WO2014150288A2 (en) 2013-03-15 2014-09-25 Insera Therapeutics, Inc. Vascular treatment devices and methods
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
JP6002319B2 (en) * 2013-05-15 2016-10-05 グンゼ株式会社 Medical materials
JP2016523147A (en) 2013-06-21 2016-08-08 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Renal denervation balloon catheter with a riding-type electrode support
CN105473092B (en) 2013-06-21 2019-05-17 波士顿科学国际有限公司 The medical instrument for renal nerve ablation with rotatable shaft
US9707036B2 (en) * 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
AU2014284558B2 (en) 2013-07-01 2017-08-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
WO2015006573A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
CN105682594B (en) 2013-07-19 2018-06-22 波士顿科学国际有限公司 Helical bipolar electrodes renal denervation dominates air bag
EP3024406B1 (en) 2013-07-22 2019-06-19 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
JP6122217B2 (en) 2013-07-22 2017-04-26 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Renal nerve ablation medical device
US10010328B2 (en) 2013-07-31 2018-07-03 NeuVT Limited Endovascular occlusion device with hemodynamically enhanced sealing and anchoring
CN105899150B (en) 2013-07-31 2018-07-27 Neuvt 有限公司 Method and apparatus for Endovascular Embolization
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10722300B2 (en) 2013-08-22 2020-07-28 Boston Scientific Scimed, Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
EP3041425B1 (en) 2013-09-04 2022-04-13 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
US10398550B2 (en) 2013-09-12 2019-09-03 St. Jude Medical, Cardiology Division, Inc. Atraumatic interface in an implant delivery device
WO2015038947A1 (en) 2013-09-13 2015-03-19 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
CN105592778B (en) 2013-10-14 2019-07-23 波士顿科学医学有限公司 High-resolution cardiac mapping electrod-array conduit
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
CN105636537B (en) 2013-10-15 2018-08-17 波士顿科学国际有限公司 Medical instrument sacculus
WO2015057961A1 (en) 2013-10-18 2015-04-23 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires and related methods of use and manufacture
WO2015061457A1 (en) 2013-10-25 2015-04-30 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
WO2015095538A1 (en) 2013-12-20 2015-06-25 Microvention, Inc. Vascular occlusion
JP6382989B2 (en) 2014-01-06 2018-08-29 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device with tear resistant flexible circuit assembly
US9724101B2 (en) * 2014-01-22 2017-08-08 Bandula Wijay Lumen occluding device, delivery catheter and method
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
CN106572881B (en) 2014-02-04 2019-07-26 波士顿科学国际有限公司 Substitution of the heat sensor on bipolar electrode is placed
EP3102122A1 (en) * 2014-02-06 2016-12-14 Boston Scientific Scimed, Inc. Occlusion device detachable by inflation of a balloon
US10285720B2 (en) 2014-03-11 2019-05-14 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
EP2918249B1 (en) * 2014-03-14 2020-04-29 Venus MedTech (HangZhou), Inc. Supraclavicular catheter system for transseptal access to the left atrium and left ventricle
EP3122284B1 (en) * 2014-03-27 2021-01-13 Nasser Rafiee Devices for closure of transvascular or transcameral access ports
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US9694201B2 (en) 2014-04-24 2017-07-04 Covidien Lp Method of use of an embolic implant for radio-ablative treatment
AU2015249283B2 (en) * 2014-04-25 2019-07-18 Flow Medtech, Llc Left atrial appendage occlusion device
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
EP3154452A1 (en) 2014-06-13 2017-04-19 Neuravi Limited Devices for removal of acute blockages from blood vessels
US10265086B2 (en) 2014-06-30 2019-04-23 Neuravi Limited System for removing a clot from a blood vessel
CA2999169A1 (en) 2014-09-19 2016-03-24 Flow Medtech, Inc. Left atrial appendage occlusion device delivery system
US11253278B2 (en) 2014-11-26 2022-02-22 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
JP2017535352A (en) 2014-11-26 2017-11-30 ニューラヴィ・リミテッド Clot collection device for removing obstructive clots from blood vessels
US10857012B2 (en) 2015-01-20 2020-12-08 Neurogami Medical, Inc. Vascular implant
US10736730B2 (en) 2015-01-20 2020-08-11 Neurogami Medical, Inc. Vascular implant
CN107205736B (en) 2015-01-20 2021-04-09 纽罗加米医药公司 Micrograft for treatment of intracranial aneurysm and method of use
US10925611B2 (en) 2015-01-20 2021-02-23 Neurogami Medical, Inc. Packaging for surgical implant
US11484319B2 (en) 2015-01-20 2022-11-01 Neurogami Medical, Inc. Delivery system for micrograft for treating intracranial aneurysms
EP3256200A1 (en) 2015-02-11 2017-12-20 Covidien LP Expandable tip medical devices and methods
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
US10463386B2 (en) 2015-09-01 2019-11-05 Mivi Neuroscience, Inc. Thrombectomy devices and treatment of acute ischemic stroke with thrombus engagement
CA3031482A1 (en) 2016-02-10 2017-08-17 Microvention, Inc. Devices for vascular occlusion
JP2019508201A (en) 2016-02-16 2019-03-28 インセラ セラピューティクス,インク. Suction device and fixed blood flow bypass device
CN212261512U (en) 2016-04-14 2021-01-01 特里萨·布兰德纳 Device for removing tissue from a body lumen
EP3454794B1 (en) 2016-05-13 2021-04-14 St. Jude Medical, Cardiology Division, Inc. Systems for device implantation
WO2017205617A1 (en) * 2016-05-26 2017-11-30 Nanostructures, Inc. System and methods for embolized occlusion of neurovascular aneurysms
US10420563B2 (en) * 2016-07-08 2019-09-24 Neurogami Medical, Inc. Delivery system insertable through body lumen
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
KR102457315B1 (en) 2016-08-17 2022-10-24 뉴라비 리미티드 A thrombus recovery system to remove an occlusive thrombus from a blood vessel
MX2019002565A (en) 2016-09-06 2019-09-18 Neuravi Ltd A clot retrieval device for removing occlusive clot from a blood vessel.
WO2018053314A1 (en) 2016-09-16 2018-03-22 Greg Mirigian Occlusive implants with fiber-based release structures
CN113215721B (en) 2016-10-14 2023-02-17 因赛普特斯医学有限责任公司 Knitting machine and method of use
WO2018156833A1 (en) 2017-02-23 2018-08-30 DePuy Synthes Products, Inc. Aneurysm device and delivery system
WO2018156962A1 (en) 2017-02-24 2018-08-30 Inceptus Medical LLC Vascular occlusion devices and methods
US11812968B2 (en) * 2017-05-10 2023-11-14 Lifetech Scientific (Shenzhen) Co. Ltd. Left atrial appendage occluder
US11298145B2 (en) 2017-05-12 2022-04-12 Covidien Lp Retrieval of material from vessel lumens
US10722257B2 (en) 2017-05-12 2020-07-28 Covidien Lp Retrieval of material from vessel lumens
US11191555B2 (en) 2017-05-12 2021-12-07 Covidien Lp Retrieval of material from vessel lumens
US10709464B2 (en) 2017-05-12 2020-07-14 Covidien Lp Retrieval of material from vessel lumens
US11129630B2 (en) 2017-05-12 2021-09-28 Covidien Lp Retrieval of material from vessel lumens
CN110831523B (en) 2017-06-12 2022-09-13 柯惠有限合伙公司 Tool for sheathing a treatment device, and associated systems and methods
US10478322B2 (en) 2017-06-19 2019-11-19 Covidien Lp Retractor device for transforming a retrieval device from a deployed position to a delivery position
US10575864B2 (en) 2017-06-22 2020-03-03 Covidien Lp Securing element for resheathing an intravascular device and associated systems and methods
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
WO2019075444A1 (en) 2017-10-14 2019-04-18 Inceptus Medical. Llc Braiding machine and methods of use
DE102017130564A1 (en) * 2017-12-19 2019-06-19 Phenox Gmbh Implant for aneurysms
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11589872B2 (en) 2018-01-31 2023-02-28 Nanostructures, Inc. Vascular occlusion devices utilizing thin film nitinol foils
EP3773251A1 (en) 2018-04-10 2021-02-17 Medstar Health Embolization scaffold devices
US11058430B2 (en) * 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11051825B2 (en) 2018-08-08 2021-07-06 DePuy Synthes Products, Inc. Delivery system for embolic braid
US10842498B2 (en) 2018-09-13 2020-11-24 Neuravi Limited Systems and methods of restoring perfusion to a vessel
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11406416B2 (en) 2018-10-02 2022-08-09 Neuravi Limited Joint assembly for vasculature obstruction capture device
US11076861B2 (en) * 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11564692B2 (en) 2018-11-01 2023-01-31 Terumo Corporation Occlusion systems
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
US11324513B2 (en) 2018-12-17 2022-05-10 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
ES2910600T3 (en) 2019-03-04 2022-05-12 Neuravi Ltd Powered Clot Recovery Catheter
WO2020190620A1 (en) * 2019-03-15 2020-09-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
CN113573765A (en) 2019-03-15 2021-10-29 后续医疗股份有限公司 Silk device for treating vascular defects
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US10653425B1 (en) 2019-05-21 2020-05-19 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
JP2021041169A (en) 2019-09-11 2021-03-18 ニューラヴィ・リミテッド Expandable mouth catheter
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11839725B2 (en) 2019-11-27 2023-12-12 Neuravi Limited Clot retrieval device with outer sheath and inner catheter
US11779364B2 (en) 2019-11-27 2023-10-10 Neuravi Limited Actuated expandable mouth thrombectomy catheter
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
US11944327B2 (en) 2020-03-05 2024-04-02 Neuravi Limited Expandable mouth aspirating clot retrieval catheter
US11633198B2 (en) 2020-03-05 2023-04-25 Neuravi Limited Catheter proximal joint
US11883043B2 (en) 2020-03-31 2024-01-30 DePuy Synthes Products, Inc. Catheter funnel extension
US11759217B2 (en) 2020-04-07 2023-09-19 Neuravi Limited Catheter tubular support
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11937836B2 (en) 2020-06-22 2024-03-26 Neuravi Limited Clot retrieval system with expandable clot engaging framework
US11395669B2 (en) 2020-06-23 2022-07-26 Neuravi Limited Clot retrieval device with flexible collapsible frame
US11439418B2 (en) 2020-06-23 2022-09-13 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
US11937837B2 (en) 2020-12-29 2024-03-26 Neuravi Limited Fibrin rich / soft clot mechanical thrombectomy device
US11872354B2 (en) 2021-02-24 2024-01-16 Neuravi Limited Flexible catheter shaft frame with seam
US11937839B2 (en) 2021-09-28 2024-03-26 Neuravi Limited Catheter with electrically actuated expandable mouth
CN113855145B (en) * 2021-10-29 2023-06-30 微创神通医疗科技(上海)有限公司 Hemangioma plugging device, hemangioma plugging treatment device and hemangioma plugging system
WO2023081340A1 (en) * 2021-11-05 2023-05-11 Microvention, Inc. Devices for treatment of vascular defects

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4848343A (en) * 1986-10-31 1989-07-18 Medinvent S.A. Device for transluminal implantation
US5192297A (en) * 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
US5344426A (en) * 1990-04-25 1994-09-06 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5571135A (en) * 1993-10-22 1996-11-05 Scimed Life Systems Inc. Stent delivery apparatus and method
US5772668A (en) * 1992-06-18 1998-06-30 American Biomed, Inc. Apparatus for placing an endoprosthesis
US6096034A (en) * 1996-07-26 2000-08-01 Target Therapeutics, Inc. Aneurysm closure device assembly
US6110198A (en) * 1995-10-03 2000-08-29 Medtronic Inc. Method for deploying cuff prostheses
US6152956A (en) * 1997-01-28 2000-11-28 Pierce; George E. Prosthesis for endovascular repair of abdominal aortic aneurysms
US6379379B1 (en) * 1998-05-05 2002-04-30 Scimed Life Systems, Inc. Stent with smooth ends

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735201A (en) 1986-01-30 1988-04-05 The Beth Israel Hospital Association Optical fiber with detachable metallic tip for intravascular laser coagulation of arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5108407A (en) 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5258042A (en) * 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
US5368566A (en) * 1992-04-29 1994-11-29 Cardiovascular Dynamics, Inc. Delivery and temporary stent catheter having a reinforced perfusion lumen
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5415637A (en) * 1993-04-14 1995-05-16 Advanced Cardiovascular Systems, Inc. Temporary stenting catheter with drug delivery capabilities
US5405322A (en) * 1993-08-12 1995-04-11 Boston Scientific Corporation Method for treating aneurysms with a thermal source
US5797903A (en) * 1996-04-12 1998-08-25 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces
US5857998A (en) * 1994-06-30 1999-01-12 Boston Scientific Corporation Stent and therapeutic delivery system
JPH10504738A (en) 1994-07-08 1998-05-12 マイクロベナ コーポレイション Medical device forming method and vascular embolization device
JP3007022B2 (en) * 1995-05-19 2000-02-07 株式会社カネカメディックス High frequency power supply for heating
US5676685A (en) 1995-06-22 1997-10-14 Razavi; Ali Temporary stent
US6019757A (en) * 1995-07-07 2000-02-01 Target Therapeutics, Inc. Endoluminal electro-occlusion detection apparatus and method
US5749894A (en) 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5830213A (en) * 1996-04-12 1998-11-03 Ep Technologies, Inc. Systems for heating and ablating tissue using multifunctional electrode structures
US5853411A (en) * 1996-01-19 1998-12-29 Ep Technologies, Inc. Enhanced electrical connections for electrode structures
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5749342A (en) 1996-09-03 1998-05-12 Chao; Raymond Moveable aperture for alteration of intake manifold cross sectional area
US5941249A (en) 1996-09-05 1999-08-24 Maynard; Ronald S. Distributed activator for a two-dimensional shape memory alloy
US5980554A (en) * 1997-05-05 1999-11-09 Micro Therapeutics, Inc. Wire frame partial flow obstruction for aneurysm treatment
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US5928260A (en) 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
GB9715241D0 (en) 1997-07-18 1997-09-24 Jeffree Martin A Device for treating aneurysms
ES2272007T3 (en) 1997-08-04 2007-04-16 Boston Scientific Limited OCLUSION SYSTEM FOR PREPARATION OF AN ANEURISM.
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
WO1999008607A1 (en) 1997-08-05 1999-02-25 Boston Scientific Limited Detachable aneurysm neck bridge
US5916235A (en) * 1997-08-13 1999-06-29 The Regents Of The University Of California Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities
US6401719B1 (en) * 1997-09-11 2002-06-11 Vnus Medical Technologies, Inc. Method of ligating hollow anatomical structures
US6917834B2 (en) * 1997-12-03 2005-07-12 Boston Scientific Scimed, Inc. Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates
US6036720A (en) * 1997-12-15 2000-03-14 Target Therapeutics, Inc. Sheet metal aneurysm neck bridge
US5935148A (en) * 1998-06-24 1999-08-10 Target Therapeutics, Inc. Detachable, varying flexibility, aneurysm neck bridge
US6152144A (en) * 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
US6428558B1 (en) * 1999-03-10 2002-08-06 Cordis Corporation Aneurysm embolization device
US6391037B1 (en) * 2000-03-02 2002-05-21 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6346117B1 (en) * 2000-03-02 2002-02-12 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4848343A (en) * 1986-10-31 1989-07-18 Medinvent S.A. Device for transluminal implantation
US5344426A (en) * 1990-04-25 1994-09-06 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5192297A (en) * 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
US5772668A (en) * 1992-06-18 1998-06-30 American Biomed, Inc. Apparatus for placing an endoprosthesis
US5571135A (en) * 1993-10-22 1996-11-05 Scimed Life Systems Inc. Stent delivery apparatus and method
US6110198A (en) * 1995-10-03 2000-08-29 Medtronic Inc. Method for deploying cuff prostheses
US6096034A (en) * 1996-07-26 2000-08-01 Target Therapeutics, Inc. Aneurysm closure device assembly
US6152956A (en) * 1997-01-28 2000-11-28 Pierce; George E. Prosthesis for endovascular repair of abdominal aortic aneurysms
US6379379B1 (en) * 1998-05-05 2002-04-30 Scimed Life Systems, Inc. Stent with smooth ends

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803395B2 (en) 2003-05-15 2010-09-28 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US20060178694A1 (en) * 2003-05-19 2006-08-10 Secant Medical, Llc Tissue distention device and related methods for therapeutic intervention
US7122043B2 (en) 2003-05-19 2006-10-17 Stout Medical Group, L.P. Tissue distention device and related methods for therapeutic intervention
US8758395B2 (en) 2003-05-19 2014-06-24 Septrx, Inc. Embolic filtering method and apparatus
US20050049681A1 (en) * 2003-05-19 2005-03-03 Secant Medical, Llc Tissue distention device and related methods for therapeutic intervention
US7648532B2 (en) 2003-05-19 2010-01-19 Septrx, Inc. Tissue distention device and related methods for therapeutic intervention
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
EP1920724A1 (en) * 2006-11-07 2008-05-14 Medtronic Vascular, Inc. Cutting radio frequency catheter for creating fenestrations in graft cloth
US7963960B2 (en) 2006-11-07 2011-06-21 Medtronic Vascular, Inc. Cutting radio frequency catheter for creating fenestrations in graft cloth
US20120271337A1 (en) * 2007-04-16 2012-10-25 Hans-Reiner Figulla Occluder For Occluding an Atrial Appendage and Production Process Therefor
US9826980B2 (en) * 2007-04-16 2017-11-28 Occlutech Holding Ag Occluder for occluding an atrial appendage and production process therefor
US9161758B2 (en) * 2007-04-16 2015-10-20 Occlutech Holding Ag Occluder for occluding an atrial appendage and production process therefor
US20160015397A1 (en) * 2007-04-16 2016-01-21 Occlutech Holding Ag Occluder For Occluding An Atrial Appendage And Production Process Therefor
WO2008157507A3 (en) * 2007-06-15 2009-03-05 Nfocus Neuromedical Inc Blood flow diverters and aneurysm covering devices
WO2008157507A2 (en) * 2007-06-15 2008-12-24 Nfocus Neuromedical, Inc. Blood flow diverters and aneurysm covering devices
US8663301B2 (en) 2007-12-11 2014-03-04 Cornell University Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US8728141B2 (en) 2007-12-11 2014-05-20 Cornell University Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen
US9763665B2 (en) 2007-12-11 2017-09-19 Cornell University Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US8956475B2 (en) 2007-12-11 2015-02-17 Howard Riina Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US8968382B2 (en) 2007-12-11 2015-03-03 Cornell University Method and apparatus for restricting flow through an opening in the side wall
US9486224B2 (en) 2007-12-11 2016-11-08 Cornell University Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US8747597B2 (en) 2008-04-21 2014-06-10 Covidien Lp Methods for making braid-ball occlusion devices
US9585669B2 (en) 2008-04-21 2017-03-07 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US9039726B2 (en) 2008-04-21 2015-05-26 Covidien Lp Filamentary devices for treatment of vascular defects
US11844528B2 (en) 2008-04-21 2023-12-19 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US8974487B2 (en) 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US20110046658A1 (en) * 2008-05-01 2011-02-24 Aneuclose Llc Aneurysm occlusion device
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
US9095342B2 (en) 2009-11-09 2015-08-04 Covidien Lp Braid ball embolic device features
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US10004511B2 (en) 2011-03-25 2018-06-26 Covidien Lp Vascular remodeling device
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US11147563B2 (en) 2011-03-25 2021-10-19 Covidien Lp Vascular remodeling device
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US10828182B2 (en) 2011-09-29 2020-11-10 Covidien Lp Vascular remodeling device
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US11654037B2 (en) 2011-09-29 2023-05-23 Covidien Lp Vascular remodeling device
US9924959B2 (en) 2012-11-06 2018-03-27 Covidien Lp Multi-pivot thrombectomy device
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US11406405B2 (en) 2012-11-06 2022-08-09 Covidien Lp Multi-pivot thrombectomy device
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US11786253B2 (en) 2012-11-13 2023-10-17 Covidien Lp Occlusive devices
US11690628B2 (en) 2012-11-13 2023-07-04 Covidien Lp Occlusive devices
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9901472B2 (en) 2013-01-17 2018-02-27 Covidien Lp Methods and apparatus for luminal stenting
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US11389309B2 (en) 2013-03-15 2022-07-19 Covidien Lp Occlusive device
US11389174B2 (en) 2014-04-30 2022-07-19 Cerus Endovascular Limited Occlusion device
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
US11357510B2 (en) 2015-09-23 2022-06-14 Covidien Lp Occlusive devices
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US11648013B2 (en) 2016-03-11 2023-05-16 Cerus Endovascular Limited Occlusion device
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11679458B2 (en) 2019-11-04 2023-06-20 Covidien Lp Devices, systems, and methods for treating aneurysms
US11685007B2 (en) 2019-11-04 2023-06-27 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11717924B2 (en) 2019-11-04 2023-08-08 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods

Also Published As

Publication number Publication date
EP1198270A4 (en) 2004-11-03
US20020143349A1 (en) 2002-10-03
US6746468B1 (en) 2004-06-08
AU2004201784A1 (en) 2004-05-27
AU773570B2 (en) 2004-05-27
US20110082491A1 (en) 2011-04-07
AU5458000A (en) 2000-12-18
CA2375660A1 (en) 2000-12-07
WO2000072909A1 (en) 2000-12-07
EP1198270A1 (en) 2002-04-24
AU2004201784A8 (en) 2004-05-27
US6375668B1 (en) 2002-04-23

Similar Documents

Publication Publication Date Title
US6746468B1 (en) Devices and methods for treating vascular malformations
US8597320B2 (en) Devices and methods for treating vascular malformations
EP1335772A2 (en) Device and methods for treating vascular malformations
JP7282514B2 (en) Aneurysm device and delivery system
US11547418B2 (en) Embolic implant and method of use
JP6529083B2 (en) Filament device for treatment of vascular disorders
JP6110427B2 (en) System and method for sealing an anatomical opening
JP4108273B2 (en) Aneurysm occlusion and reinforcement method and device
JP3930189B2 (en) Embolization coil deployment system with improved embolization coil
KR102137221B1 (en) Ballstent device and methods of use
JP2019126734A5 (en)
AU2002258372A1 (en) Device and methods for treating vascular malformations

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: STRYKER CORPORATION, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CONCENTRIC MEDICAL, INC.;REEL/FRAME:051003/0472

Effective date: 20191030